<|box_start|>078 200 921 241<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Catalytic Stereoselective Glycosidation with Glycosyl Diphenyl Phosphates: Rapid Construction of 1,2-cis-α-Glycosidic Linkages<|md_end|>
<|box_start|>081 260 919 294<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Miyuki Koshiba, Noritoshi Suzuki, Ryoichi Arihara, Toshifumi Tsuda, Hisanori Nambu, Seiichi Nakamura, and Shunichi Hashimoto*[a]<|md_end|>
<|box_start|>259 302 741 316<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Dedicated to Professor Ryoji Noyori on the occasion of his 70th birthday<|md_end|>
<|box_start|>076 344 343 454<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Abstract: A commercially available \(0.1\mathrm{M}\) solution of \(\mathrm{HClO_4}\) in dioxane has been shown to catalyze the glycosidation of glycosyl diphenyl phosphates. The per- O- benzyl- protected glucosyl and galactosyl donors and the 3,4,6- tri\(o\) - acetyl- 2- azido- 2- deoxygalactosyl donor each react with a range of ac <|txt_contd|><|md_end|>
<|box_start|>366 344 633 384<|box_end|><|ref_start|>text<|ref_end|><|md_start|>ceptor alcohols in the presence of \(0.05- \) 0.2 equiv of \(\mathrm{HClO_4}\) in dioxane \(/\mathrm{Et}_2\mathrm{O}\) 1:1) to afford glycosides in good yields<|md_end|>
<|box_start|>378 405 620 447<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Keywords: carbohydrates \(\cdot\) glycosylation \(\cdot\) perchloric acid \(\cdot\) phosphates \(\cdot\) stereoselectivity<|md_end|>
<|box_start|>655 344 922 440<|box_end|><|ref_start|>text<|ref_end|><|md_start|>with good to excellent \(\alpha\) selectivities. The synthetic utility of this glycosidation method was demonstrated by a stereoselective synthesis of the \(\alpha\) - galactosylceramide KRN7000, an activator of natural killer (NK) T cells through CD1d molecules.<|md_end|>
<|box_start|>231 484 328 499<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Introduction<|md_end|>
<|box_start|>076 513 483 750<|box_end|><|ref_start|>text<|ref_end|><|md_start|>The development of a general stereoselective glycosidation reaction has been an enduring problem in carbohydrate chemistry for nearly 30 years. Since the 1,2- cis- \(\alpha\) - glycoside is one of the most important structural units and is ubiquitously found in natural oligosaccharides and glycoconjugates, considerable effort has been devoted to the stereocontrolled construction of this linkage. While 1,2- trans- \(\beta\) - glycosides can be prepared with the use of anchimeric assistance of a neighboring participating group, the formation of 1,2- cis- \(\alpha\) - glycosides usually requires donors with a non- assisting functionality at C- 2, leading to a mixture of anomers despite the favorable stereoelectronic preference. One approach involves the use of the in situ aromerization concept introduced by Lemieux, wherein stable \(\alpha\) - glycosyl halides are equilibrated via ion- pair intermediates to reactive \(\beta\) counterparts, which, upon \(\mathrm{S_N2}\) - like displacement by acceptor alcohols, predominantly afford \(\alpha\) - glycosides. In most <|txt_contd|><|md_end|>
<|box_start|>515 485 922 651<|box_end|><|ref_start|>text<|ref_end|><|md_start|>cases, observed selectivities are good to excellent, but the reaction requires very reactive glycosyl halides and relatively long reaction times. Another approach has focused on the use of beneficial \(\alpha\) - directing effects of ethereal solvents.[6,7] Ether, THF, and dioxane have been utilized for this purpose. In particular, promoters possessing the perchlorate counterion have been successfully employed in combination with these solvents.[8,9] In addition to these approaches, an intramolecular glycosidation strategy,[10,11] the use of a donor with a bulky protecting group at O- 6[12] or the use of an acceptor alcohol in a \(C_4\) conformation,[13] and the remote group participation strategy[9h,14] have been reported.<|md_end|>
<|box_start|>515 652 922 874<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Over the last two decades, we have been concerned with the development of novel stereocontrolled glycosidation reactions capitalizing on phosphorus- containing leaving groups.[15- 21] For stereoselective construction of 1,2- cis- \(\alpha\) - glycosidic linkages, we developed S- (2- O- benzyl- \(\beta\) - glycosyl)- \(N,N,N^{\prime},N^{\prime}\) - tetramethyl- \(N^{\prime \prime}\) - phenylphosphorodiamidimidothioates as donors, which provided glycosides in good yields with excellent \(\alpha\) selectivities \((\alpha /\beta = 91:9 - > 99:1)\) upon activation with 2,6- lutidinium \(p\) - toluenesulfonate (LPTS) in the presence of \(\mathrm{Bu_4NI}\) [17] We also demonstrated that glycosidations with glycosyl diethyl phosphites, when treated with 2,6- di- tert- butylpyridinium iodide (DTBPI) in the presence of \(\mathrm{Bu_4NI}\) predominantly gave \(\alpha\) - glycosides.[19e] Independent of our studies, Waldmann and Schmid reported that exposure of \(\alpha\) - glucosyl phosphates to a 1M solution of \(\mathrm{LiClO_4}\) in \(\mathrm{CH}_2\mathrm{Cl}_2\) in the presence of LiI resulted in formation of the<|md_end|>
--------------------------------------------------
<|box_start|>077 082 484 317<|box_end|><|ref_start|>text<|ref_end|><|md_start|>corresponding glycosyl iodides, which reacted with glycoside alcohols to afford di- and trisaccharides in modest yields with good to excellent \(\alpha\) selectivities.[22] It is noteworthy that all of these methods are based on Lemieux's in situ anomerization concept and glycosyl iodides[23] are formed as common reactive intermediates. Compared to glycosyl bromides originally employed by Lemieux and co- workers,[5] the corresponding \(\beta\)- glycosyl iodide intermediates exhibit high reactivities toward \(\mathrm{S}_{\mathrm{N}}2\)- like displacement; however, long times (3- 72 h) are required for completion of the reaction. In contrast to the in situ anomerization- based methods, documentation of the \(\alpha\)- directing effect of ethereal solvents, especially in glycosidations with glycosyl phosphates,[24] is limited. Herein, we report a rapid, high- yielding and stereoselective synthesis of 1,2- cis- \(\alpha\)- glycosides by \(\mathrm{HClO_4}\)- catalyzed glycosidation with glycosyl diphenyl phosphates in dioxane/Et2O (1:1) or dioxane.<|md_end|>
<|box_start|>191 344 371 359<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Results and Discussion<|md_end|>
<|box_start|>203 367 357 380<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Reaction Optimization<|md_end|>
<|box_start|>077 387 484 693<|box_end|><|ref_start|>text<|ref_end|><|md_start|>At the outset of this work, we speculated that an enhanced \(\alpha\) selectivity would be obtained by the use of less- reactive acceptor alcohols such as 4- O- unprotected glycosides owing to the kinetic anomeric effect (KAE).[35] Therefore, highly reactive 6- O- unprotected glucoside 3 was chosen as an acceptor alcohol, and glucosyl diphenyl phosphate 1 \((\alpha /\beta =\) 98:2) and glucosyl diethyl phosphite 2 \((\alpha /\beta = 80:20)\) were evaluated as glycosyl donors. Addition of 1,5 equiv of a promoter to a mixture of donor 1 or 2, 1.1 equiv of acceptor 3, and \(5\mathrm{\AA}\) molecular sieves (M.S.) in \(\mathrm{Et}_2\mathrm{O}\) afforded disaccharide 4, the \(\alpha /\beta\) ratio of which was assayed by HPLC (Zorbax Sil column). Several promoters were screened in the reaction, and the results are compiled in Table 1. All of the reactions proceeded to full conversion within \(30\mathrm{min}\) at \(0^\circ \mathrm{C}\). Initial experiments revealed that trimethylsilyl triflate (TMSOTf) promoted glycosidation of phosphate 1 with alcohol 3 in \(\mathrm{Et}_2\mathrm{O}\) to afford disaccharide 4 in \(93\%\) yield with good \(\alpha\) selectivity \((\alpha /\beta = 79:21)\), whereas a 56:44 mixture was obtained from phosphite 2 (Table 1, entries 1 vs 2). Of various metal triflates screened, \(\mathrm{Cu(OTf)_2}\) and \(\mathrm{Sn(OTf)_2}\) were found to activate both phosphate 1 and phosphite 2, providing disaccharide 4 in modest yields, albeit in lower <|txt_contd|><|md_end|>
<|box_start|>078 726 223 738<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Abstract in Japanese:<|md_end|>
<|box_start|>082 741 478 862<|box_end|><|ref_start|>text<|ref_end|><|md_start|>\(\alpha\) 7.2. 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. 46. 47. 48. 49. 50. 51. 52. 53. 54. 55. 56. 57. 58. 59. 60. 61. 62. 63. 64. 65. 66. 67. 68. 69. 70. 71. 72. 73. 74. 75. 76. 77. 78. 79. 80. 81. 82. 83. 84. 85. 86. 87. 88. 89. 90. 91. 92. 93. 94. 95. 96. 97. 98. 99. 100. 101. 102. 103. 104. 105. 106. 107. 108. 109. 110. 111. 112. 113. 114. 115. 116. 117. 118. 119. 120. 121. 122. 123. 124. 125. 126. 127. 128. 129. 130. 131. 132. 133. 134. 135. 136. 137. 138. 139. 140. 141. 142. 143. 144. 145. 146. 147. 148. 149. 150. 151. 152. 153. 154. 155. 156. 157. 158. 159. 160. 161. 162. 163. 164. 165. 166. 167. 168. 169. 170. 171. 172. 173. 174. 175. 176. 177. 178. 179. 180. 181. 182. 183. 184. 185. 186. 187. 188. 189. 190. 191. 192. 193. 194. 195. 196. 197. 198. 199. 200. 201. 202. 203. 204. 205. 206. 207. 208. 209. 210. 211. 212. 213. 214. 215. 216. 217. 218. 219. 220. 221. 222. 223. 224. 225. 226. 227. 228. 229. 230. 231. 232. 233. 234. 235. 236. 237. 238. 239. 240. 241. 242. 243. 244. 245. 246. 247. 248. 249. 250. 251. 252. 253. 254. 255. 256. 257. 258. 259. 260. 261. 262. 263. 264. 265. 266. 267. 268. 269. 270. 271. 272. 273. 274. 275. 276. 277. 278. 279. 280. 281. 282. 283. 284. 285. 286. 287. 288. 289. 290. 291. 292. 293. 294. 295. 296. 297. 298. 299. 300. 301. 302. 303. 304. 305. 306. 307. 308. 309. 310. 311. 312. 313. 314. 315. 316. 317. 318. 319. 320. 321. 322. 323. 324. 325. 326. 327. 328. 329. 330. 331. 332. 333. 334. 335. 336. 337. 338. 339. 340. 341. 342. 343. 344. 345. 346. 347. 348. 349. 350. 351. 352. 353. 354. 355. 356. 357. 358. 359. 360. 361. 362. 363. 364. 365. 366. 367. 368. 369. 370. 371. 372. 373. 374. 375. 376. 377. 378. 379. 380. 381. 382. 383. 384. 385. 386. 387. 388. 389. 390. 391. 392. 393. 394. 395. 396. 397. 398. 399. 400. 401. 402. 403. 404. 405. 406. 407. 408. 409. 410. 411. 412. 413. 414. 415. 416. 417. 418. 419. 420. 421. 422. 423. 424. 425. 426. 427. 428. 429. 430. 431. 432. 433. 434. 435. 436. 437. 438. 439. 440. 441. 442. 443. 444. 445. 446. 447. 448. 449. 450. 451. 452. 453. 454. 455. 456. 457. 458. 459. 460. 461. 462. 463. 464. 465. 466. 467. 468. 469. 470. 471. 472. 473. 474. 475. 476. 477. 478. 479. 480. 481. 482. 483. 484. 485. 486. 487. 488. 489. 490. 491. 492. 493. 494. 495. 496. 497. 498. 499. 500. 501. 502. 503. 504. 505. 506. 507. 508. 509. 510. 511. 512. 513. 514. 515. 516. 517. 518. 519. 520. 521. 522. 523. 524. 525. 526. 527. 528. 529. 530. 531. 532. 533. 534. 535. 536. 537. 538. 539. 540. 541. 542. 543. 544. 545. 546. 547. 548. 549. 550. 551. 552. 553. 554. 555. 556. 557. 558. 559. 560. 561. 562. 563. 564. 565. 566. 567. 568. 569. 570. 571. 572. 573. 574. 575. 576. 577. 578. 579. 580. 581. 582. 583. 584. 585. 586. 587. 588. 589. 590. 591. 592. 593. 594. 595. 596. 597. 598. 599. 600. 601. 602. 603. 604. 605. 606. 607. 608. 609. 610. 611. 612. 613. 614. 615. 616. 617. 618. 619. 620. 621. 622. 623. 624. 625. 626. 627. 628. 629. 630. 631. 632. 633. 634. 635. 636. 637. 638. 639. 640. 641. 642. 643. 644. 645. 646. 647. 648. 649. 650. 651. 652. 653. 654. 655. 656. 657. 658. 659. 660. 661. 662. 663. 664. 665. 666. 667. 668. 669. 670. 671. 672. 673. 674. 675. 676. 677. 678. 679. 680. 681. 682. 683. 684. 685. 686. 687. 688. 689. 690. 691. 692. 693. 694. 695. 696. 697. 698. 699. 700. 701. 702. 703. 704. 705. 706. 707. 708. 709. 710. 711. 712. 713. 714. 715. 716. 717. 718. 719. 720. 721. 722. 723. 724. 725. 726. 727. 728. 729. 730. 731. 732. 733. 734. 735. 736. 737. 738. 739. 740. 741. 742. 743. 744. 745. 746. 747. 748. 749. 750. 751. 752. 753. 754. 755. 756. 757. 758. 759. 760. 761. 762. 763. 764. 765. 766. 767. 768. 769. 770. 771. 772. 773. 774. 775. 776. 777. 778. 779. 780. 781. 782. 783. 784. 785. 786. 787. 788. 789. 790. 791. 792. 793. 794. 795. 796. 797. 798. 799. 800. 801. 802. 803. 804. 805. 806. 807. 808. 809. 810. 811. 812. 813. 814. 815. 816. 817. 818. 819. 820. 821. 822. 823. 824. 825. 826. 827. 828. 829. 830. 831. 832. 833. 834. 835. 836. 837. 838. 839. 840. 841. 842. 843. 844. 845. 846. 847. 848. 849. 850. 851. 852. 853. 854. 855. 856. 857. 858. 859. 860. 861. 862. 863. 864. 865. 866. 867. 868. 869. 870. 871. 872. 873. 874. 875. 876. 877. 878. 879. 880. 881. 882. 883. 884. 885. 886. 887. 888. 889. 890. 891. 892. 893. 894. 895. 896. 897. 898. 899. 900. 901. 902. 903. 904. 905. 906. 907. 908. 909. 910. 911. 912. 913. 914. 915. 916. 917. 918. 919. 920. 921. 922. 923. 924. 925. 926. 927. 928. 929. 930. 931. 932. 933. 934. 935. 936. 937. 938. 939. 940. 941. 942. 943. 944. 945. 946. 947. 948. 949. 950. 951. 952. 953. 954. 955. 956. 957. 958. 959. 960. 961. 962. 963. 964. 965. 966. 967. 968. 969. 970. 971. 972. 973. 974. 975. 976. 977. 978. 979. 980. 981. 982. 983. 984. 985. 986. 987. 988. 989. 990. 991. 992. 993. 994. 995. 996. 997. 998. 999. 100. 101. 102. 103. 104. 105. 106. 107. 108. 109. 110. 111. 112. 113. 114. 115. 116. 117. 118. <|md_end|>
<|box_start|>514 081 922 093<|box_end|><|ref_start|>table_caption<|ref_end|><|md_start|>Table 1. Effects of promoters in the glycosidation of per-O-benzyl-protected glucosyl donors 1 and 2 with alcohol 3.<|md_end|>
<|box_start|>514 105 924 328<|box_end|><|ref_start|>table<|ref_end|><|md_start|><fcel>Entry<fcel>Donor[a]<fcel>Promoter<fcel>t [min]<fcel>Yield [%]<fcel>α/β[b]<nl>
<fcel>1<fcel>1<fcel>TMSOTf<fcel>5<fcel>93<fcel>79:21<nl>
<fcel>2<fcel>2<fcel>TMSOTf<fcel>5<fcel>91<fcel>56:44<nl>
<fcel>3<fcel>1<fcel>Cu(OTf)2<fcel>10<fcel>70<fcel>71:29<nl>
<fcel>4<fcel>2<fcel>Cu(OTf)2<fcel>5<fcel>76<fcel>60:40<nl>
<fcel>5<fcel>1<fcel>Sn(OTf)2<fcel>30<fcel>59<fcel>48:52<nl>
<fcel>6<fcel>2<fcel>Sn(OTf)2<fcel>5<fcel>58<fcel>58:42<nl>
<fcel>7<fcel>1<fcel>TMSCIO4[c]<fcel>5<fcel>95<fcel>83:17<nl>
<fcel>8<fcel>2<fcel>TMSCIO4[c]<fcel>5<fcel>94<fcel>76:24<nl>
<fcel>9<fcel>1<fcel>HClO4[d]<fcel>5<fcel>91<fcel>84:16<nl>
<fcel>10<fcel>2<fcel>HClO4[d]<fcel>5<fcel>93<fcel>78:22<nl>
<|md_end|>
<|box_start|>515 329 922 386<|box_end|><|ref_start|>table_footnote<|ref_end|><|md_start|>[a] Anomeric ratio of the donors: 1, 98:2; 2, 80:20. [b] The ratio was determined by HPLC (column, Zorbax Sil, \(4.6\times 250\mathrm{mm}\) : eluent, hexane/ THF 6:1; flow rate, \(1.5\mathrm{mL}\mathrm{min}^{-1}\) ). [c] Prepared from TMSCl and \(\mathrm{AgClO_4}\) [d] Prepared from BuCl and \(\mathrm{AgClO_4}\) \(\mathrm{Bn} =\) benzyl, \(\mathrm{TMS} =\) trimethylsilyl, \(\mathrm{Tf} =\) trifluoromethanesulfonyl.<|md_end|>
<|box_start|>515 399 922 804<|box_end|><|ref_start|>text<|ref_end|><|md_start|>\(\alpha\) selectivities (Table 1, entries 3- 6). As expected from the precedents, the use of a \(0.1\mathrm{M}\) solution of \(\mathrm{TMSClO_4}\) in toluene, prepared from TMSCl and \(\mathrm{AgClO_4}\) [26] for the activation of phosphate 1 resulted in the formation of disaccharide 4 with improved \(\alpha\) selectivity \((\alpha /\beta = 83:17\) ,Table 1, entry 7). Interestingly, lower \(\alpha\) selectivity \((\alpha /\beta = 76:24)\) was obtained using phosphite 2 as a donor under identical conditions (Table 1, entry 8). These results suggest that, for inexplicable reasons, the leaving group plays an important role in reaction selectivity. In addition to Lewis acids, some Brønsted acids have been shown to activate glycosyl phosphites.[27] The beneficial effect of perchlorate counterion is evident from the result using perchloric acid \(\mathrm{(HClO_4)}\) prepared from \(t\mathrm{BuCl}\) and \(\mathrm{AgClO_4}\) in toluene,[91] as a promoter for the glycosidation of phosphite 2, whereby an \(\alpha\) selectivity \((\alpha /\beta =\) 76:24) comparable to that with \(\mathrm{TMSClO_4}\) was obtained (Table 1, entries 10 vs 8). To our surprise, \(\mathrm{HClO_4}\) also activated phosphate 1 in \(\mathrm{Et}_2\mathrm{O}\) at \(0^\circ \mathrm{C}\) providing an 84:16 mixture in favor of \(\alpha\)- disaccharide 4α in \(91\%\) combined yield (Table 1, entry 9). Owing to the advantage of phosphate 1 over phosphite 2 as a donor, phosphate 1 was employed for optimization of the glycosidation parameters. Although a \(0.1\mathrm{M}\) solution of anhydrous \(\mathrm{HClO_4}\) in dioxane can be purchased from Kishida Chemical Co., Ltd., its low concentration has precluded its use in our investigation. Accordingly, both \(\mathrm{TMSClO_4}\) and \(\mathrm{HClO_4}\) should be prepared prior to use. Therefore, our initial efforts focused on the use of the more conveniently handled \(0.5\mathrm{M}\) solution of \(\mathrm{TMSClO_4}\) in toluene.<|md_end|>
<|box_start|>515 805 922 874<|box_end|><|ref_start|>text<|ref_end|><|md_start|>To evaluate the beneficial effect of ethereal solvents, we next undertook a solvent survey in the \(\mathrm{TMSClO_4}\)- promoted glycosidation of phosphate 1 with alcohol 3 at \(0^\circ \mathrm{C}\) (Table 2). As expected, employment of solvents such as \(\mathrm{CH}_2\mathrm{Cl}_2\) and toluene led to a significant decline in stereose- <|md_end|>
--------------------------------------------------
<|box_start|>077 081 341 092<|box_end|><|ref_start|>table_caption<|ref_end|><|md_start|>Table 2. Effects of solvents on stereoselectivity.<|md_end|>
<|box_start|>074 094 485 275<|box_end|><|ref_start|>table<|ref_end|><|md_start|><fcel>Entry<fcel>Solvent<fcel>T [°C]<fcel>Yield [%]<fcel>α/β[a]<nl>
<fcel>1<fcel>Et2O<fcel>0<fcel>85<fcel>83:17<nl>
<fcel>2<fcel>CH2Cl2<fcel>0<fcel>89<fcel>62:38<nl>
<fcel>3<fcel>toluene<fcel>0<fcel>87<fcel>66:34<nl>
<fcel>4<fcel>THF<fcel>0<fcel>91<fcel>62:38<nl>
<fcel>5<fcel>tBuOMe<fcel>0<fcel>82<fcel>82:18<nl>
<fcel>6<fcel>dioxane<fcel>25<fcel>87<fcel>88:12<nl>
<fcel>7<fcel>dioxane/Et2O 1:1<fcel>0<fcel>97<fcel>88:12<nl>
<|md_end|>
<|box_start|>076 276 483 298<|box_end|><|ref_start|>table_footnote<|ref_end|><|md_start|>[a] The ratio was determined by HPLC column, Zorbax Sil, \(4.6\times\) \(250\mathrm{mm}\) ; eluent, hexane/THF 6:1; flow rate, \(1.5\mathrm{mL}\mathrm{min}^{-1}\) -<|md_end|>
<|box_start|>076 331 483 455<|box_end|><|ref_start|>text<|ref_end|><|md_start|>lectivity Table 2, entries 2 and 3).In contrast, with the lone exception of THF Table 2, entry 4),good to high \(\alpha\) selectivities were obtained in ethereal solvents, with dioxane being the optimal solvent, although the high melting point of dioxane precluded a direct comparison (Table 2, entries 1, 5, and 6).[28] Since the use of \(\mathrm{Et}_2\mathrm{O}\) as a cosolvent had no effect on reaction selectivity Table 2, entry 7), the mixed solvent system, which allowed the glycosidation to be run at lower temperatures, was chosen for further development.<|md_end|>
<|box_start|>076 457 483 554<|box_end|><|ref_start|>text<|ref_end|><|md_start|>An examination of the temperature profile of the reaction in dioxane \(/\mathrm{Et}_2\mathrm{O}\) 1:1) demonstrated that a decrease in the reaction temperature to \(- 20^{\circ}\mathrm{C}\) was accompanied by a decrease in \(\alpha\) selectivity Table 3, entries 1 vs 2 and 3).Since the \(\alpha\) selectivity and yield obtained at \(0^\circ \mathrm{C}\) were comparable to those at \(25^{\circ}C\) Table 3, entries 2 vs 3),further optimization was performed at \(0^\circ \mathrm{C}\) To date, glycosylations of alco<|md_end|>
<|box_start|>075 587 483 610<|box_end|><|ref_start|>table_caption<|ref_end|><|md_start|>Table 3. Effects of temperature, amount of promoter and anomeric composition of the donor on stereoselectivity.<|md_end|>
<|box_start|>075 610 484 804<|box_end|><|ref_start|>table<|ref_end|><|md_start|><fcel>Entry[a]<fcel>Donor 1 α/β<fcel>Promoter (equiv)<fcel>T [°C]<fcel>Yield [%]<fcel>α/β[b]<nl>
<fcel>1<fcel>98:2<fcel>TMSClO4(1:5)<fcel>-20<fcel>92<fcel>80:20<nl>
<fcel>2<fcel>98:2<fcel>TMSClO4(1:5)<fcel>0<fcel>97<fcel>88:12<nl>
<fcel>3<fcel>98:2<fcel>TMSClO4(1:5)<fcel>25<fcel>92<fcel>89:11<nl>
<fcel>4<fcel>98:2<fcel>TMSClO4(0:2)<fcel>0<fcel>93<fcel>90:10<nl>
<fcel>5<fcel>98:2<fcel>TMSClO4(0:05)<fcel>0<fcel>94<fcel>91:9<nl>
<fcel>6<fcel>98:2<fcel>HCIO4(0.05)<fcel>0<fcel>90<fcel>91:9<nl>
<fcel>7<fcel>5:95<fcel>HCIO4(0.05)<fcel>0<fcel>92<fcel>88:12<nl>
<fcel>8[c]<fcel>5:95<fcel>HCIO4(0.05)<fcel>0<fcel>79<fcel>90:10<nl>
<|md_end|>
<|box_start|>075 805 484 873<|box_end|><|ref_start|>table_footnote<|ref_end|><|md_start|>[a] A promoter was added to a mixture of donor 1, alcohol 3, and 5-AM.S. in dioxane \(/\mathrm{Et}_2\mathrm{O}\) 1:1).[b] The ratio was determined by HPLC column,Zorbax Sil, \(4.6\times 250\mathrm{mm}\) eluent, hexane/THF 6:1; flow rate, \(1.5\mathrm{mL}\mathrm{min}^{-1}\) .[c] After stirring a mixture of donor 1 and \(\mathrm{HCIO_4}\) in dioxane \(/\mathrm{Et}_2\mathrm{O}\) 1:1) at \(0^\circ \mathrm{C}\) for \(30\mathrm{min}\) a solution of alcohol 3 in dioxane \(/\mathrm{Et}_2\mathrm{O}\) 1:1) was added at \(0^\circ \mathrm{C}\)<|md_end|>
<|box_start|>515 078 922 740<|box_end|><|ref_start|>text<|ref_end|><|md_start|>hols with glycosyl phosphates have not been rendered catalytic.[29] Despite the lack of precedent, the foregoing finding that phosphate 1 can be activated by \(\mathrm{HClO_4}\) prompted us to investigate the glycosidation under catalytic conditions in anticipation that \(\mathrm{HClO_4}\) released upon glycosidation (see below), could function as a promoter. Gratifyingly, in the presence of 0.2 equiv of \(\mathrm{TMSClO_4}\), alcohol 3 underwent reaction with glycosyl phosphate 1 at \(0^\circ \mathrm{C}\) to provide the disaccharide 4 with high \(\alpha\)- selectivity \((\alpha /\beta = 90:10\), Table 3, entry 4). Finally, complete conversion to disaccharide 4 within \(5\mathrm{min}\) was realized by employing only 0.05 equiv of \(\mathrm{TMSClO_4}\); no change in stereoselectivity \((\alpha /\beta = 91:9)\) or chemical yield \((94\%)\) was observed at this loading (Table 3, entry 5). As previously discussed, \(\mathrm{HClO_4}\) was comparable to \(\mathrm{TMSClO_4}\) when used in the reaction of phosphate 1 with alcohol 3 in \(\mathrm{Et}_2\mathrm{O}\) at \(0^\circ \mathrm{C}\) (Table 1, entry 7 vs 9). The catalytic potency of \(\mathrm{HClO_4}\), in conjunction with the use of dioxane as an optimal solvent, led us to explore the glycosidation under catalytic conditions using a commercially available \(\mathrm{HClO_4}\) solution. Fortunately, the \(\mathrm{HClO_4}\)- catalyzed glycosidation of phosphate 1 with alcohol 3 reached completion in less than \(5\mathrm{min}\), giving virtually the same result as that obtained with \(\mathrm{TMSClO_4}\) (Table 3, entry 6).[30] The use of commercially available \(\mathrm{HClO_4}\) solution in place of \(\mathrm{TMSClO_4}\) obviated the need to prepare the promoter from explosive \(\mathrm{AgClO_4}\) for every reaction. It is well documented that thermodynamically less- stable \(\beta\)- phosphates anomerize to the corresponding \(\alpha\)- phosphates in the presence of acids.[31] On the basis of precedent, it is speculated that the stereoselectivities are independent of the anomeric composition of the phosphate donor when glycosidations are performed under acidic conditions.[32] Surprisingly, the use of phosphate 1 \((\alpha /\beta = 5:95)\)[33] gave disaccharide 4 with minor erosion in \(\alpha\) selectivity \((\alpha /\beta = 88:12\), Table 3, entry 7). While the reason for the decreased \(\alpha\) selectivity is not clear at present, we postulated that alcohol 3 is so reactive that the \(\beta\)- phosphate \(1\beta\) could not completely anomerize to the \(\alpha\)- phosphate \(1\alpha\) prior to glycosidation.[34] Indeed, a permuted order of addition improved the stereoselectivity of the glycosidation using phosphate 1 of \(\alpha /\beta\) ratio 5:95 (Table 3, entry 8). Since a synthetically useful level of stereoselection was possible using the \(\beta\)- phosphate, stereoselective preparation of \(\alpha\)- phosphates is not a requirement for the construction of 1,2- cis- \(\alpha\)- glycosidic linkages. However, caution should be exercised when performing glycosylations of reactive alcohols such as 3 using reactive donors containing a substantial amount of \(\beta\) anomer.<|md_end|>
<|box_start|>664 757 771 770<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Reaction Scope<|md_end|>
<|box_start|>515 778 922 874<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Having optimized the reaction conditions, the scope of the \(\mathrm{HClO_4}\)- catalyzed glycosidation was explored. Results of experiments for probing the scope of the alcohol component (Figure 1) with glucosyl phosphate 1 \((\alpha /\beta = 98:2)\) are summarized in Table 4. \(\mathrm{HClO_4}\)- catalyzed glycosidations of 1 in dioxane \(/\mathrm{Et}_2\mathrm{O}\) (1:1) in the presence of 5- Å M.S. at \(0^\circ \mathrm{C}\) provided rapid and high- yielding access to a broad range of 1,2- <|md_end|>
--------------------------------------------------
<|box_start|>104 082 455 435<|box_end|><|ref_start|>image<|ref_end|><|md_start|>![]('img_url')<|md_end|>
<|box_start|>076 442 368 454<|box_end|><|ref_start|>image_caption<|ref_end|><|md_start|>Figure 1. Acceptor alcohols and products in Table 4.<|md_end|>
<|box_start|>076 492 480 515<|box_end|><|ref_start|>table_caption<|ref_end|><|md_start|>Table 4. \(\mathrm{HCIO_4}\) catalyzed glycosidation of per-O-benzyl-protected glucosyl diphenyl phosphate 1 with acceptor alcohols.<|md_end|>
<|box_start|>074 516 485 669<|box_end|><|ref_start|>table<|ref_end|><|md_start|><fcel>Entry<fcel>ROH<fcel>t [min]<fcel>Glycoside<fcel>Yield [%]<fcel>α/β[a]<nl>
<fcel>1<fcel>5<fcel>20<fcel>11<fcel>80<fcel>91:9<nl>
<fcel>2<fcel>6<fcel>5<fcel>12<fcel>95<fcel>89:11<nl>
<fcel>3<fcel>7<fcel>10<fcel>13<fcel>85<fcel>86:14<nl>
<fcel>4<fcel>8<fcel>20<fcel>14<fcel>94<fcel>89:11<nl>
<fcel>5<fcel>9<fcel>30<fcel>15<fcel>86<fcel>87:13<nl>
<fcel>6<fcel>10<fcel>20<fcel>16<fcel>85<fcel>85:15<nl>
<|md_end|>
<|box_start|>076 670 483 704<|box_end|><|ref_start|>table_footnote<|ref_end|><|md_start|>[a] The ratio for the glycoside was determined by HPLC (column, Zorbax Sil, \(4.6\times 250\mathrm{mm}\) : eluent, hexane/THF 2:1 or hexane/AcOEt 10:1-20:1; flow rate, \(1.0 - 1.5\mathrm{mLmin^{-1}}\)<|md_end|>
<|box_start|>076 736 483 874<|box_end|><|ref_start|>text<|ref_end|><|md_start|>cis- \(\alpha\) glycosides; reaction times were typically \(5 - 30\mathrm{min}\) and \(\alpha\) selectivities ranged from 85:15 to 91:9. We previously reported that a limitation of DTBPI- promoted glycosidation was encountered with the less- reactive \(4 - O\) - unprotected glucoside 5, which, upon reaction with diethyl phosphite 2 in the presence of \(\mathrm{Bu_4NI}\) for \(48\mathrm{h}\) afforded disaccharide 11 in \(59\%\) yield, albeit with excellent \(\alpha\) selectivity \((\alpha /\beta = 95:5)\) [19e] Under the optimized conditions, the alcohol 5 underwent glycosylation with donor 1 within \(20\mathrm{min}\) to provide the disaccharide 11 in \(80\%\) yield with a slightly lower stereoselec <|txt_contd|><|md_end|>
<|box_start|>515 082 922 290<|box_end|><|ref_start|>text<|ref_end|><|md_start|>tivity \((\alpha /\beta = 91:9\) Table 4, entry 1). It is noteworthy that alcohols 6 and 7 bearing acid- sensitive acetal or epoxy groups were safely glycosylated under these conditions with good \(\alpha\) selectivities (Table 4, entries 2 and 3).A steroidal alcohol (cholesterol, 8) and a tert- alcohol (1- adamantanol, 9) were also successfully utilized in this reaction, and \(\alpha\) - glycosides \(14\alpha\) and \(15\alpha\) were preferentially formed (Table 4, entries 4 and 5). It has been demonstrated that Lewis acid promoted glycosidations with phenols are accompanied by \(O\to C\) glycoside rearrangements, resulting in the formation of \(C\) - aryl glycosides.[35] The advantage of employing a Bronsted acid \(\mathrm{(HClO_4)}\) as a promoter becomes evident for the stereoselective synthesis of aryl glycosides, as the present method delivered \(p\) - methoxyphenyl (PMP) glucoside 16 free from contamination by rearranged products (Table 4, entry 6).<|md_end|>
<|box_start|>515 291 922 387<|box_end|><|ref_start|>text<|ref_end|><|md_start|>In an effort to expand the scope of the glycosidation method, we next examined the reaction of diphenyl phosphates 17 \((\alpha /\beta = 98:2)\) and 18 \((\alpha /\beta = 33:67)\) in the D- galacto series (Table 5, Figure 2). Consistent with the general trend,[36] per- \(o\) - benzyl- protected galactosyl donor 17 afforded better reactivity relative to the glucosyl donor 1, thereby allowing the glycosidation to reach completion within \(5\mathrm{min}\)<|md_end|>
<|box_start|>513 415 922 437<|box_end|><|ref_start|>table_caption<|ref_end|><|md_start|>Table 5. \(\mathrm{HCIO_4}\) catalyzed glycosidation of galactosyl diphenyl phosphates 17 and 18.<|md_end|>
<|box_start|>513 438 922 612<|box_end|><|ref_start|>table<|ref_end|><|md_start|><fcel>Entry<fcel>Donor[a]<fcel>ROH<fcel>Equil HClO4<fcel>T [°C]<fcel>t [min]<fcel>Glycoside<fcel>Yield [%]<fcel>α/β[b]<nl>
<fcel>1<fcel>17<fcel>3<fcel>0.05<fcel>0<fcel>5<fcel>23<fcel>88<fcel>75:25<nl>
<fcel>2<fcel>17<fcel>5<fcel>0.05<fcel>0<fcel>5<fcel>24<fcel>77<fcel>90:10<nl>
<fcel>3<fcel>17<fcel>19<fcel>0.05<fcel>0<fcel>5<fcel>25<fcel>82<fcel>87:13<nl>
<fcel>4<fcel>17<fcel>20<fcel>0.05<fcel>0<fcel>5<fcel>26<fcel>91<fcel>87:13<nl>
<fcel>5<fcel>18<fcel>21<fcel>0.2<fcel>25<fcel>120<fcel>27<fcel>82<fcel>91:9<nl>
<fcel>6<fcel>18<fcel>22<fcel>0.2<fcel>25<fcel>360<fcel>28<fcel>78<fcel>92:8<nl>
<|md_end|>
<|box_start|>514 614 922 660<|box_end|><|ref_start|>table_footnote<|ref_end|><|md_start|>[a] Anomeric ratio of the donors: 17, 98:2; 18, 33:67. [b] The ratio for the glycoside was determined by HPLC (column, Zorbax Sil, \(4.6\times 250\mathrm{mm}\) . eluent, hexane/THF 4:1-6:1 or hexane/AcOEt 5:1; flow rate, \(0.5- \) \(1.5\mathrm{mLmin^{-1}}\) \(\mathrm{AC} =\) acetyl.<|md_end|>
<|box_start|>515 694 922 804<|box_end|><|ref_start|>text<|ref_end|><|md_start|>even with the less- reactive alcohol 5 (Table 5, entry 2). While galactosides were obtained in good to high yields in all cases, the selectivities were not as favorable as those obtained with 1 (Table 5, entries 1- 4). Selectivities appeared to depend on the reactivity of the acceptor alcohols: High \(\alpha\) selectivities were observed in the reaction with less- reactive 4- \(o\) - unprotected glycosides 5 and 19, but the primary alcohol 3 leads to poor \(\alpha\) selectivity \((\alpha /\beta = 75:25)\)<|md_end|>
<|box_start|>514 806 922 874<|box_end|><|ref_start|>text<|ref_end|><|md_start|>The scope of the \(\mathrm{HCIO_4}\) catalyzed glycosidation is not limited to the use of per- \(o\) - benzyl- protected donors. When 3,4,6- tri- \(o\) - acetyl- 2- azido- 2- deoxygalactosyl diphenyl phosphate (18, \(\alpha /\beta = 33:67\) was used as a donor, 0.2 equiv of \(\mathrm{HCIO_4}\) an elevated temperature \((25^{\circ}\mathrm{C})\) and longer reaction<|md_end|>
--------------------------------------------------
<|box_start|>076 082 485 327<|box_end|><|ref_start|>image<|ref_end|><|md_start|>![]('img_url')<|md_end|>
<|box_start|>075 333 483 357<|box_end|><|ref_start|>image_caption<|ref_end|><|md_start|>Figure 2. Acceptor alcohols and products in Table 5. Fmoc = 9-fluorenylmethoxycarbonyl.<|md_end|>
<|box_start|>076 387 292 540<|box_end|><|ref_start|>text<|ref_end|><|md_start|>times were required to effect complete conversion owing to the attenuated reactivity of the donor.[37] Excellent stereocontrol was realized for serine and threonine derivatives 21 and 22, leading to predominant formation of \(\alpha\)- glycosides \(27\alpha\) and \(28\alpha\), which correspond to constituents of \(O\)- linked glycoproteins (Table 5, entries 5 and 6).<|md_end|>
<|box_start|>341 381 893 533<|box_end|><|ref_start|>image<|ref_end|><|md_start|>![]('img_url')<|md_end|>
<|box_start|>310 538 497 550<|box_end|><|ref_start|>image_caption<|ref_end|><|md_start|>Scheme 1. Synthesis of KRN7000.<|md_end|>
<|box_start|>113 576 447 588<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Synthesis of \(\alpha\)-Galactosylceramide KRN7000 (29)<|md_end|>
<|box_start|>076 595 484 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>In 1993, a research group of Kirin Brewery Co., Ltd. reported the isolation and characterization of agelasphins, the first glycosylceramides found as \(\alpha\)- linked galactosides.[8] Owing to their significant antitumor activities in mice, these molecules hold promise as new lead structures for the development of antitumor therapeutics. Therefore, the Kirin group synthesized various analogues and concluded on the basis of their structure- activity relationships that (2S,3S,4R)- 1- O- (\(\alpha\)- D- galactopyranosyl)- 2- (\(N\)- hexacosanolylamino)- 1,3,4- octadecanetriol (29), named KRN7000, was the compound of choice for clinical trials.[39] With regard to the mechanism of action, KRN7000 was shown to act as a ligand for the CD1d receptor on antigen- presenting cells to form a complex which binds to natural killer (NK) T cells, leading to the stimulation of a cascade of cytokines.[40,41] Not surprisingly, the potent biological properties have aroused considerable interest in KRN7000 within the medicinal and synthetic chemistry communities, and routes to KRN7000 have been reported by 12 groups to date.[42] We then considered that a synthesis of KRN7000 would provide a stringent test for the <|txt_contd|><|md_end|>
<|box_start|>515 082 922 136<|box_end|><|ref_start|>text<|ref_end|><|md_start|>glycosidation method presented herein, since glycosidations employing ceramides as acceptor alcohols frequently suffer from poor reactivity presumably owing to hydrogen- bond donation from the amide \(\mathrm{N - H}\) group.[43]<|md_end|>
<|box_start|>515 137 922 360<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Ceramide 30 was readily prepared from D- galactose according to literature procedures (Scheme 1).[44] At this stage, we noticed that the insolubility of 30 in \(\mathrm{Et}_2\mathrm{O}\) precluded the use of a solvent mixture of dioxane \(\mathrm{Et}_2\mathrm{O}\). Since ceramide 30 is sparingly soluble in dioxane, we opted to run the reaction in dioxane at a low concentration \((0.02\mathrm{M})\) at room temperature. Our initial attempt to couple galactosyl diphenyl phosphate 17 \((\alpha /\beta = 98:2)\) and alcohol 30 under the optimized conditions resulted in the formation of a trace amount of glycoside 31 with complete recovery of unreacted starting materials. We surmised that the result is attributed to both the low concentration and the presence of the amide moiety that would buffer the acidity of the promoter. After considerable experimentation, we found that the use of 0.5 equiv of \(\mathrm{HClO_4}\) was sufficient for the reaction to proceed to completion, providing glycoside 31 in \(80\%\) yield with an \(\alpha /\beta\)<|md_end|>
<|box_start|>515 583 922 777<|box_end|><|ref_start|>text<|ref_end|><|md_start|>ratio of 90:10. Examination of the amount of donor used in the glycosidation revealed that a slight excess of diphenyl phosphate 17 (1.1 equiv) was beneficial to both chemical yield \((92\%)\) and diastereoselectivity \((\alpha /\beta = 92:8)\). As compared to the precedents wherein an excess amount of donors (at least 1.5 equiv) was utilized for the glycosylation of ceramide derivatives to give \(\alpha\)- galactosides in good yields \((53 - 74\%)\),[42a- c,f,j,k] the method presented herein offers the advantage of high product yield when using approximately equimolar proportions of glycosyl donor 17 and acceptor 30. After chromatographic separation of the anomers, the \(\alpha\)- anomer \(31\alpha\) was subjected to hydrogenolysis in the presence of \(20\% \mathrm{Pd(OH)_2 / C}\) to give KRN7000, whose data were identical in all respects with those previously reported.<|md_end|>
<|box_start|>626 799 811 812<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Mechanistic Considerations<|md_end|>
<|box_start|>515 820 922 874<|box_end|><|ref_start|>text<|ref_end|><|md_start|>A control experiment established that the anomeric ratio of glycoside 4 \((\alpha /\beta = 2:98)\) did not change upon exposure to a stoichiometric amount of \(\mathrm{HClO_4}\) in the presence of \(5 - \mathrm{\AA}\) M.S. in dioxane \(\mathrm{Et}_2\mathrm{O}\) (1:1) even under reflux for \(5\mathrm{h}\), imply<|md_end|>
--------------------------------------------------
<|box_start|>076 081 483 136<|box_end|><|ref_start|>text<|ref_end|><|md_start|>ing that the observed \(\alpha\) selectivity is the result of kinetic control. On the basis of this result, we propose the reaction pathway for \(\mathrm{HCIO_4}\)- catalyzed glycosidation using glycosyl diphenyl phosphates as glycosyl donors (Scheme 2). Diphen<|md_end|>
<|box_start|>086 158 474 375<|box_end|><|ref_start|>image<|ref_end|><|md_start|>![]('img_url')<|md_end|>
<|box_start|>076 382 483 405<|box_end|><|ref_start|>image_caption<|ref_end|><|md_start|>Scheme 2. Plausible mechanism of the \(\mathrm{HCIO_4}\)-catalyzed glycosidation with glycosyl diphenyl phosphates.<|md_end|>
<|box_start|>077 429 483 776<|box_end|><|ref_start|>text<|ref_end|><|md_start|>yl phosphate 32 is activated by protonation at the phosphoryl oxygen atom,[45] resulting in cleavage of the phosphate group to provide an equilibrium mixture of contact ion pair (CIP) 34 and glycosyl perchlorates[41] \(35\alpha\) and \(35\beta\), along with diphenyl phosphate. Since it is speculated, in analogy to most organic perchlorates, that glycosyl perchlorates \(35\alpha\) and \(35\beta\) are unstable, the equilibration between 34, \(35\alpha\), and \(35\beta\) would lie toward CIP 34, especially at high temperatures. In addition, ethereal solvents are capable of stabilization of CIP 34 and facilitate the formation of solvent- separated ion pair (SSIP) 36. Axial attack of acceptor alcohols from the \(\alpha\) face of CIP 34 or SSIP 36 is favored owing to KAE, leading to the preferential formation of \(\alpha\)- glycosides and the regeneration of \(\mathrm{HCIO_4}\). The trend for \(\alpha\) selectivity to increase with increasing temperature (Table 3, entry 1 vs 2) provides strong support for the proposed mechanism because of a large equilibrium preference for CIP 34 at a higher temperature. The reason for the enhanced \(\alpha\) selectivity in dioxane is unclear,[46] however, low anionicity of dioxane would avoid formation of oxonium ions by solvent participation,[47] thus promoting the glycosidation through CIP 34 and SSIP 36. The rationale for the difference in stereoselectivity between phosphate 1 and phosphite 2 is not fully understood at this time, and further studies to address this issue will be forthcoming.<|md_end|>
<|box_start|>232 804 328 819<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Conclusions<|md_end|>
<|box_start|>076 833 483 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>This study documents the stereoselective glycosylation of alcohols with glycosyl diphenyl phosphates in the presence of an acid catalyst. Commercially available \(0.1\mathrm{M}\) solution of<|md_end|>
<|box_start|>517 082 922 317<|box_end|><|ref_start|>text<|ref_end|><|md_start|>\(\mathrm{HCIO_4}\) has been found to be an excellent catalyst for the transformation, providing glycosides in high yields with high \(\alpha\) selectivities. A wide range of glycosyl acceptors, including steroidal alcohols, tert- alcohols, and phenols as well as glycoside alcohols bearing acid- sensitive acetal or epoxy groups, can be employed in this coupling. The glycosyl donor is not confined to highly reactive benzyl- protected glucosyl and galactosyl diphenyl phosphates, and the scope of this reaction is extended to include less- reactive 3,4,6- tri- \(o\) - acetyl- 2- azido- 2- deoxygalactosyl diphenyl phosphate as a donor. Of particular note is the development of a simple reaction protocol that employs a commercially available promoter, low catalyst loading (as little as \(5\mathrm{mol}\%\) catalyst), and moderate temperature \((0 - 25^{\circ}\mathrm{C})\) conditions that render this glycosidation particularly attractive from a preparative standpoint. We have also demonstrated that this method was successfully utilized in the synthesis of KRN7000. <|md_end|>
<|box_start|>517 318 922 553<|box_end|><|ref_start|>text<|ref_end|><|md_start|>With regard to the activation of glycosyl phosphates, stoichiometric amounts of Lewis acids such as TMSOTf,[15] \(\mathrm{BF_3}\cdot \mathrm{OEt_2}\) [48] and \(\mathrm{LiClO_4}\) [22] have been employed as promoters, and protic acids have been reported to be ineffective for this purpose.[29] Therefore, the method present herein is the first example of the use of a protic acid as a promoter in the glycosidation with glycosyl phosphates. Seeberger and coworkers proposed that a driving force of silyl triflate promoted glycosidation using glycosyl phosphates is the formation of a stoichiometric amount of silyl phosphate as a byproduct.[29] On the basis of this speculation, they developed a catalytic method employing a TMS ether as an acceptor and TfOH as a catalyst.[29] However, direct catalytic glycosylation of alcohol acceptors does not appear to have been precedented prior to the present study. This is also the first example of direct catalytic glycosidation of glycosyl phosphates with alcohols.<|md_end|>
<|box_start|>517 555 922 706<|box_end|><|ref_start|>text<|ref_end|><|md_start|>To date, there is no generally applicable direct method for the construction of 1,2- cis- \(\alpha\)- glycosides from glycosyl phosphates because, even without a participating group at C- 2, 1,2- trans- \(\beta\)- glycosidic linkages are readily formed with these donors. Thus, we have now developed a stereoselective entry to either 1,2- cis- \(\alpha\)- glycosides or 1,2- trans- \(\beta\)- glycosides using glycosyl phosphates as common glycosyl donors by appropriate choice of the reaction conditions. This method complements glycosidations based on the in situ anomerization concept and should find wide application in organic synthesis.<|md_end|>
<|box_start|>634 739 804 753<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Experimental Section<|md_end|>
<|box_start|>517 766 560 776<|box_end|><|ref_start|>title<|ref_end|><|md_start|># General<|md_end|>
<|box_start|>517 783 922 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Melting points were measured on a Büchi 535 digital melting point apparatus and are uncorrected. Optical rotations were measured on a JASCO P- 1030 digital polarimeter with a sodium lamp (589 nm). Infrared (IR) spectra were recorded on a JASCO FT/IR- 5300 spectrometer and absorbance bands are reported in wavenumbers \((\mathrm{cm}^{- 1})\). Proton nuclear magnetic resonance \((^{1}\mathrm{H}\mathrm{NMR})\) spectra were recorded on a JEOL JNM- AL400 (400 MHz), JNM- ECX400P (400 MHz), JNM- ECA500 (500 MHz), or Bruker ALX500 (500 MHz) spectrometer with tetramethylcellulose<|md_end|>
--------------------------------------------------
<|box_start|>077 081 484 241<|box_end|><|ref_start|>text<|ref_end|><|md_start|>thylsilane \((\delta_{\mathrm{H}} = 0.00\mathrm{ppm})\) \(\mathrm{CHCl}_3\) \((\delta_{\mathrm{H}} = 7.26\mathrm{ppm})\) or pyridine \((\delta_{\mathrm{H}} =\) \(8.73\mathrm{ppm})\) as an internal standard. Coupling constants \((J)\) are reported in hertz \((\mathrm{Hz})\) . Abbreviations of multiplicity are as follows: s, singlet; d, doublet; t, triplet; \(\mathfrak{q}_i\) quartet; m, multiplet; br, broad. Data are presented as follows: chemical shift, multiplicity, coupling constants, integration, and assignment. Carbon nuclear magnetic resonance \((^{13}\mathrm{C}\) NMR) spectra were recorded on a JEOL JNM- AL400 \((100\mathrm{MHz})\) or Bruker ARX500 \((126\mathrm{MHz})\) spectrometer with \(\mathrm{CDCl}_3\) \((\delta_{\mathrm{C}} = 77.0\mathrm{ppm})\) or \([\mathrm{D}_5]\) pyridine \((\delta_{\mathrm{C}} = 149.9\mathrm{ppm})\) as an internal standard. Phosphorus nuclear magnetic resonance \(\mathrm{(^{31}P}\) NMR) spectra were recorded on a JEOL EX270 \((109\mathrm{MHz})\) spectrometer with \(\mathrm{H}_3\mathrm{PO}_4\) \((\delta_{\mathrm{P}} = 0.00\mathrm{ppm})\) as an external standard. Fast atom bombardment (FAB) mass spectra were obtained on a JEOL JMS- HX110 spectrometer by the Center for Instrumental Analysis, Hokkaido University.<|md_end|>
<|box_start|>076 243 484 358<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Column chromatography was carried out on Kanto silica gel \(60\mathrm{N}\) \((40- \) \(50\mu \mathrm{m}\) or \(63 - 210\mu \mathrm{m})\) or Wakogel C- 200 \((75 - 150\mu \mathrm{m})\) .Analytical and preparative thin layer chromatography TLC) was carried out on \(0.25\mathrm{mm}\) Merck Kieselgel \(60\mathrm{F}_{254}\) plates. Visualization was accomplished with ultraviolet light and anisaldehyde or phosphomolybdic acid stain, followed by heating. Analytical high- performance liquid chromatography (HPLC) was performed on a JASCO PU- 980 and UV- 970 (detector, \(\lambda =\) \(254\mathrm{nm}\) .Retention times \((r_{\mathrm{R}})\) and peak ratios were determined with a Shimadzu Chromatopac C- R6A. Hexane was HPLC grade, and was filtered and degassed prior to use.<|md_end|>
<|box_start|>076 360 484 428<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Reagents and solvents were purified by standard means or used as received unless otherwise noted. Dehydrated \(\mathrm{CH}_2\mathrm{Cl}_2\) THF (stabilizer free), and toluene were purchased from Kanto Chemical Co., Inc. Dioxane was distilled from sodium metal/benzophenone ketyl prior to use. 5- A molecular sieves were finely ground in a mortar and heated in vacuo at \(200^{\circ}\mathrm{C}\) for \(12\mathrm{h}\)<|md_end|>
<|box_start|>076 431 484 476<|box_end|><|ref_start|>text<|ref_end|><|md_start|>All reactions were conducted under an argon atmosphere. 3,4,6- Tri- Oacetyl- 2- azido- 2- deoxy- D- galactopyranosyl phosphate phosphate \(\mathbf{(18)^{[15c]}}\) and2,3,4,6- tetra- O- benzyl- \(\alpha\) - D- glucopyranosyltrichloroacetimidate[49] were prepared according to literature procedures.<|md_end|>
<|box_start|>077 490 253 500<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Preparation of Glycosyl Donors<|md_end|>
<|box_start|>076 508 484 837<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Typical procedure for preparation of glycosyl diphenyl phosphates: 2,3,4,6- Tetra- \(o\) - benzyl- \(\mathbb{D}\) glucopyranosyl diphenyl phosphate (1; \(\alpha /\beta =\) 98:2) was prepared using a slight modification of the literature procedure. Diphenyl chlorophosphate \((0.70\mathrm{mL}\) \(3.34\mathrm{mmol}\) was added to a stirred solution of 2,3,4,6- tetra- \(o\) - benzyl- D- glucopyranose \((1.5\mathrm{g}\) \(2.78\mathrm{mmol}\) and DMAP \((1.02\mathrm{g},8.34\mathrm{mmol})\) in \(\mathrm{CH}_2\mathrm{Cl}_2\) \(18\mathrm{mL}\) at \(0^\circ \mathrm{C}\) After stirring for \(30\mathrm{min}\) the reaction was quenched with crushed ice, followed by stirring for \(10\mathrm{min}\) .The mixture was poured into a two- layer mixture of AcOEt \((10\mathrm{mL})\) and saturated aqueous \(\mathrm{NaHCO_3}\) \((10\mathrm{mL})\) and the whole mixture was extracted with AcOEt \((50\mathrm{mL})\) .The organic extract was successively washed with saturated aqueous \(\mathrm{NaHCO_3}\) \((30\mathrm{mL})\) and brine \((30\mathrm{mL})\) and dried over anhydrous \(\mathrm{Na_2SO_4}\) .Filtration and evaporation in vacuo furnished the crude product \((2.37\mathrm{g})\) which was purified by column chromatography (silica gel \(40\mathrm{g}\) hexane/AcOEt 3:1 with \(3\%\) \(\mathrm{Et}_3\mathrm{N}\) to give diphenyl phosphate \(\mathbf{1}^{[50]}\) \(1.54\mathrm{g},75\%\) \(\alpha /\beta = 98:2\) as a white solid. The anomeric \(\alpha /\beta\) ratio of the product was determined by \(^{31}\mathrm{P}\) NMR. Data for \(\alpha\) anomeric \(\mathbf{I}\alpha\) . \(R_{\mathrm{f}} = 0.46\) (Dhexane/AcOEt 2:1) \([\alpha ]_{\mathrm{c}}^{\mathrm{[51]}} = +62.1\) \((c = 1.00\) in \(\mathrm{CHCl}_3\) [lit. \([\alpha ]_{\mathrm{c}}^{\mathrm{[51]}} = +61.9\pm 0.7\) \((c = 2.80\) in \(\mathrm{CHCl}_3\) [50] IR (film): \(\bar{\tau} = 3421\) 3062,3032,3025,2878,1948,1877,1811, 1747,1589,1490,1454,1368,1291,1187,1071,1008, \(954~\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{500~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 3.35\) dd \(J = 1.6\) \(11.9\mathrm{Hz}\) 1HH \(3\mathrm{- }6\mathrm{a}\) 3.61- 3.64 (m2HH- 2H- 6b3.72t \(J = 9.9\mathrm{Hz}\) 1HH- 43.77dd \(J = 1.6\) \(9.9\mathrm{Hz}\) 1HH- 53.88t \(J = 9.9\mathrm{Hz}\) 1HH- 4d \(\mathrm{d},J = 12.2\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.48d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OHPh}_3\) 4.51d \(J = 12.2\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.63d \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.74d \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.76d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.80d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.89d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 6.06dd \(J = 3.2\) 6.5 \((J_{\mathrm{H + P}})\) Hz, 1H; H- 1), 7.23- 7.31 ppm (m, 30H; aromatic); \(^{31}\mathrm{P}\) NMR \(\mathrm{109~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = - 12.67\) a- 12.86 ppm (b).<|md_end|>
<|box_start|>076 840 483 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>17: The reaction was performed according to the typical procedure \(7\mathrm{mL}\) \(\mathrm{CH}_2\mathrm{Cl}_2\) \(0^\circ \mathrm{C}\) \(30\mathrm{min}\) employing 2,3,4,6- tetra- \(o\) - benzyl- D- galactopyranose \((500\mathrm{mg}\) \(0.93\mathrm{mmol}\) diphenyl chlorophosphate \((0.25\mathrm{mL}\) \(1.20\mathrm{mmol}\)<|md_end|>
<|box_start|>515 082 922 276<|box_end|><|ref_start|>text<|ref_end|><|md_start|>and DMAP \((361~\mathrm{mg}\) \(2.96\mathrm{mmol}\) .The crude product \((869~\mathrm{mg})\) was purified by column chromatography (silica gel \(18\mathrm{g}\) hexane/AcOEt 5:2 with \(3\%\) \(\mathrm{Et}_3\mathrm{N}\) to give 2,3,4,6- tetra- \(o\) - benzyl- D- galactopyranosyl diphenyl phosphate[51] \((17;459\mathrm{mg}\) \(90\%\) \(\alpha /\beta = 98:2\) as a colorless oil. The anomeric \(\alpha /\beta\) ratio of the product was determined by \(^{31}\mathrm{P}\) NMR. Data for \(\alpha\) anomer 17a: \(R_{\mathrm{f}} = 0.51\) hexane/AcOEt 2:1) \([\alpha ]_{\mathrm{D}}^{23} = +56.7\) \((c = 1.01\) in \(\mathrm{CHCl}_3\) IR (film): \(\bar{\nu} = 30.63\) 3031,2919,2871,1952,1590,1490,1454, 1358,1291,1190,1110 \(957~\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{500~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 3.28\) dd \(J = 5.2\) \(8.4\mathrm{Hz}\) 1H; H- 6a3.52t \(J = 8.4\) 1H; H- 6b3.83dd \(J =\) 3.2, \(10.0\mathrm{Hz}\) 1HH- 33.97- 4.00m2HH- 4H- 54.12dt \(J = 10.0\) 3.2,1H;H- 24.35d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.38d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.55d \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.68d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.71d \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.73d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.77d \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.96d \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 6.77dd \(J = 2.3\) 6.3H- 1H;H- 1H; \(7.05 - 7.27\mathrm{ppm}\) m30H; aromatic) \(^{31}\mathrm{P}\) NMR \(\mathrm{109~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = - 12.95\) a- 17.42 ppm (b).<|md_end|>
<|box_start|>514 277 922 597<|box_end|><|ref_start|>text<|ref_end|><|md_start|>2: Diethyl chlorophosphate \((0.16\mathrm{mL}\) \(1.11\mathrm{mmol}\) was added to a stirred solution of 2,3,4,6- tetra- \(o\) - benzyl- D- glucopyranose \((500\mathrm{mg}\) \(0.93\mathrm{mmol}\) \(\alpha /\beta = 80:20\) and \(\mathrm{Et}_3\mathrm{N}\) \((0.32\mathrm{mL}\) 2.31 mmol) in \(\mathrm{CH}_2\mathrm{Cl}_2\) \(5\mathrm{mL}\) at \(- 78^{\circ}\mathrm{C}\) After \(30\mathrm{min}\) the reaction was quenched with crushed ice, followed by stirring at \(0^\circ \mathrm{C}\) for \(15\mathrm{min}\) .The whole mixture was partitioned between AcOEt \((30\mathrm{mL})\) and saturated aqueous \(\mathrm{NaHCO_3}\) \((10\mathrm{mL})\) .The organic layer was washed with brine \((2\times 15\mathrm{mL})\) and dried over anhydrous \(\mathrm{Na_2SO_4}\) Filtration and evaporation in vacuo furnished the crude product \((765\mathrm{mg})\) ,which was purified by column chromatography (silica gel \(30\mathrm{g}\) hexane/AcOEt 7:1 with \(2\%\) EtN) to give 2,3,4,6- tetra- \(o\) - benzyl- D- glucopyranosyl diethyl phosphite (2: \(544~\mathrm{mg}\) \(89\%\) \(\alpha /\beta = 80:20\) as a colorless oil. The anomeric \(\alpha /\beta\) ratio of the product was determined by \(^{31}\mathrm{P}\) NMR. \(R_{\mathrm{f}} = 0.67\) hexane/AcOEt 2:1) \([\alpha ]_{\mathrm{D}}^{23} = +47.4\) \((c = 1.02\) in \(\mathrm{CHCl}_3\) IR (film): \(\bar{\nu} = 3063\) 3030,298,2924,1952,1873,1811,1605,1497,1454, 1362,1028, \(916\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{1200~MHz}\) \(\mathrm{CDCl}_3\) data for \(\alpha\) anomer): \(\delta = 1.210\) t \(J = 6.9\mathrm{Hz}\) 3H \(\mathrm{OCH}_2\mathrm{CH}_3\) 1.213t \(J = 7.2\mathrm{Hz}\) 3H \(\mathrm{OCH}_2\mathrm{CH}_3\) 3.60dd \(J = 34\) 9.7Hz1HH- 23.62dd \(J = 1.7\) \(10.3\mathrm{Hz}\) 1H;H- 6a3.69t \(J = 9.7\mathrm{Hz}\) 1HH- 43.75dd \(J = 3.4\) \(10.3\mathrm{Hz}\) 1H H- 6b3.84- 3.95m4H \(1\times \mathrm{OCH}_2\mathrm{CH}_3\) 3.98m1HH- 53.99t \(J =\) \(9.7\mathrm{Hz}\) 1HH- 354.40d \(J = 12.1\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.49d \(J = 10.8\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.59d \(J = 12.1\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.68d \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.71d \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.81d \(J = 10.8\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.84d \(J = 10.8\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.94d \(J = 10.8\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 5.57dd \(J = 3.4\) 8.5 \((J_{\mathrm{H + P}})\) Hz1H;H- 1 \(7.16 - 7.35\mathrm{ppm}\) m20Haromatic) \(^{31}\mathrm{P}\) NMR \((67.5\mathrm{MHz}\) \(\mathrm{CDCl}_3\) 19.94d \(J =\) \(17.6\mathrm{Hz}\) C- 1a)96.9ppm d \(J = 15.7\mathrm{Hz}\) C- 1b \({}^{31}\mathrm{P}\) NMR \(\mathrm{109~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 140.05\) a)140.71ppm \((\beta)\) FAB- HRMS: \(m / z\) calcd for \(\mathrm{C_{38}H_{46}O_4P[M + H]^+}\) 661.2230,found:661.2927. <|md_end|>
<|box_start|>515 608 655 619<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Preparation of Promoters<|md_end|>
<|box_start|>514 626 922 671<|box_end|><|ref_start|>text<|ref_end|><|md_start|>\(0.5\mathrm{M}\) TMSCIO in toluene TMSCl \((0.095\mathrm{mL}\) \(0.75\mathrm{mmol}\) was added to a stirred solution of \(\mathrm{AgClO_4}\) \((155.9\mathrm{mg}\) \(0.75\mathrm{mmol}\) in toluene \((1.5\mathrm{mL})\) and the mixture was stirred for \(30\mathrm{min}\) .After standing for \(10\mathrm{min}\) without stirring, the supernatant was used for glycosidation as a promoter.[26]<|md_end|>
<|box_start|>514 673 922 720<|box_end|><|ref_start|>text<|ref_end|><|md_start|>\(0.5\mathrm{M}\) \(\mathrm{HClO_4}\) in toluene: \(\mathrm{BuCl}\) \((0.090\mathrm{mL}\) \(0.83\mathrm{mmol}\) was added to a stirred solution of \(\mathrm{AgClO_4}\) \((155.9\mathrm{mg}\) \(0.75\mathrm{mmol}\) in toluene \((1.5\mathrm{mL})\) and the mixture was stirred for \(30\mathrm{min}\) .After standing for \(10\mathrm{min}\) without stirring, the supernatatant was used for glycosidation as a promoter.[26]<|md_end|>
<|box_start|>515 730 590 741<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Glycosidation<|md_end|>
<|box_start|>515 749 922 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Typical procedure for \(\mathrm{HCOO_4}\) catalyzed glycosidation: \(\mathrm{HClO_4}\) in dioxane \((0.1\mathrm{M},0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) was added to a stirred mixture of diphenyl phosphate 1 \((77.3\mathrm{mg},0.10\mathrm{mmol})\) alcohol 3 \((51.1\mathrm{mg},0.11\mathrm{mmol})\) ,and pulverized \(5 - \mathrm{\AA}\) M.S. \((50\mathrm{mg})\) in dioxane/EtO \((1:1,1\mathrm{mL})\) at \(0^\circ \mathrm{C}\) After stirring for \(5\mathrm{min}\) the reaction was quenched with \(\mathrm{Et}_3\mathrm{N}\) \((0.1\mathrm{mL})\) and the mixture was filtrated through a celite pad. The filtrate was poured into a two- layer mixture of AcOEt \((3\mathrm{mL})\) and saturated aqueous \(\mathrm{NaHCO_3}\) \((6\mathrm{mL})\) and the whole mixture was extracted with AcOEt \((30\mathrm{mL})\) .The organic extract was successively washed with saturated aqueous \(\mathrm{NaHCO_3}\) \((10\mathrm{mL})\) and brine \((10\mathrm{mL})\) ,and dried over anhydrous \(\mathrm{Na_2SO_4}\) Filtration and evaporation in vacuo furnished the crude product \((105.8\mathrm{mg})\) ,from<|md_end|>
--------------------------------------------------
<|box_start|>076 079 484 504<|box_end|><|ref_start|>text<|ref_end|><|md_start|>which an anomeric mixture of methyl 2,3,4- tri- \(o\) - benzyl- 6- O- (2,3,4,6- tetra- \(o\) - benzyl- D- glucopyranosyl)- \(\alpha\) - D- glucopyranoside[9]488.8 mg, \(90\%\) \(\alpha /\beta = 91.9\) was obtained as a white solid after column chromatography (silica gel \(10\mathrm{g}\) hexane/AcOEt 5:1). The anomeric \(\alpha \beta\) ratio of disaccharide 4 was determined by HPLC analysis (column, Zorbax Sil, \(4.6\times\) \(250\mathrm{mm}\) eluent, hexane/THF 6:1; flow rate, \(1.5\mathrm{mLmin^{- 1}}\) ; detection, \(254~\mathrm{nm}\) . \(t_\mathrm{R}\) \(\beta\) anomer) \(= 15.8\mathrm{min}\) \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 16.4\mathrm{min}\) . The \(\alpha\) and \(\beta\) - glycosides were separated by preparative thin layer chromatography (hexane/ \(\mathrm{CH}_2\mathrm{Cl}_7\) acetone 20:20:1). Data for \(\alpha\) anomer 4a: \(R_{\mathrm{f}} = 0.62\) (hexane/AcOEt 2:1), 0.29 (hexane/ \(\mathrm{CHCl}_7\) acetone 20:20:1); \([\alpha ]_{\mathrm{D}}^{21} = +54.4\) \((c = 1.01\) in \(\mathrm{CHCl}_3\) [lit: \([\alpha ]_{\mathrm{D}}^{24} = +53\) \(c = 0.57\) in \(\mathrm{CHCl}_3\) )],[9] IR (film): \(\bar{\nu} =\) 3031,2927,1496,1455,1361,1071,1028, \(900\mathrm{cm}^{- 1}\) \(\mathrm{^1H}\) NMR \((400\mathrm{MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 3.35\) s,3H \(\mathrm{OCH}_3\) 3.44 (dd, \(J = 3.6\) 9.6 Hz,1H;H- 2)3.52- 3.55 (m, 2H; H- 6a, H- 2), 3.59- 3.66 (m, 3H; H- 4, H- 4, H- 6a), 3.70 (br d, \(J = 10.2\mathrm{Hz}\) 1H; H- 6a), 3.75- 3.82 (m, 3H; H- 4, H- 5, H- 6a), 3.95 (1d, \(J =\) 9.2, \(9.6\mathrm{Hz}\) 1H; H- 3), 3.97 (dd, \(J = 9.2\) 9.6 Hz, 1H; H- 3)4.41 d \(J =\) \(12.1\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.44d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.54d \(J =\) \(3.6\mathrm{Hz}\) 1H; H- 1)4.56d \(J = 12.1\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.57d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.62- 4.69 m3H \(3\times \mathrm{OCHPh}\) 4.70d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.76d \(J = 11.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.80d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.81d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.91d \(J = 11.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.93d \(J = 11.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.95d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.96d \(J = 3.4\mathrm{Hz}\) 1H; H- 1)7.10- 7.33 ppm (m, 35H; aromatic). Data for \(\beta\) anomer 4: \(R_{\mathrm{f}} = 0.62\) (hexane/AcOEt 2:1), 0.21 (hexane/ \(\mathrm{CHCl}_3\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{20} = 19.2\) \((c = 0.83\) in \(\mathrm{CHCl}_3\) ) [lit: \([\alpha ]_{\mathrm{D}}^{21} = +19\) \((c = 1.0\) in \(\mathrm{CHCl}_3\) )],[9] IR (film): \(\bar{\nu} = 3031\) 2913,1496,1455,1360,1069, \(1028,795\mathrm{cm}^{- 1}\) H NMR \(\mathrm{(400~MHz}\) \(\mathrm{CDCl}_3\) \(b = 3.32\) s,3H \(\mathrm{OCH}_3\) 3.43 (m, 1H; H- 5), 3.46- 3.53 (m, 3H; H- 2, H- 4, H- 2)3.56 (dd, \(J = 8.8\) \(9.4\mathrm{Hz}\) 1H; H- 43.62 (dd \(J = 8.8\) 9.0 Hz,1H; H- 33.64- 3.73 m3H H- 6a, H- 6ab)3.82 (m, 1H; H- 5)3.98 \(t = 9.2\mathrm{Hz}\) 1H; H- 3)4.17 (dd, \(J = 1.9\) \(10.7\mathrm{Hz}\) 1H; H- 6b)4.34d \(J = 7.7\mathrm{Hz}\) 1H; H- 14.50d \(J =\) \(11.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.51- 4.53 m2H2:2 \(\mathrm{OCHPh}_3\) 4.55d \(J =\) \(12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.60d \(J = 3.3\mathrm{Hz}\) 1H; H- 1)4.65d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.71d \(J = 11.1\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.74d \(J = 11.1\mathrm{Hz}\) 1H \(\mathrm{CH}_2\mathrm{Ph}_3\) 4.76- 4.81 m4H \(4\times \mathrm{OCHPh}\) 4.90d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.96d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.97d \(J = 11.1\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 7.10- 7.33 ppm (m, 35H; aromatic).<|md_end|>
<|box_start|>076 508 484 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>11: The glycosidation was performed according to the typical procedure \((1\mathrm{mL}\) dioxane \(\mathrm{Et}_2\mathrm{O}\) 1:1, \(0^\circ \mathrm{C}\) \(20\mathrm{min}\) employing diphenyl phosphate 1 \((77.3\mathrm{mg},0.10\mathrm{mmol})\) , alcohol 5 \((51.1\mathrm{mg},0.10\mathrm{mmol})\) \(\mathrm{HClO}_4\) \((0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) and pulverized 5- A (5.350.6 tetra- \(o\) anomeric mixture of) methyl 2,3,6- tri- \(o\) - benzyl- 4- O- (2,3,4,6- tetra- \(\alpha\) \(\beta = 91.9\) was obtained as a colorless oil from the crude product \((105.8\mathrm{mg})\) after column chromatography (silica gel \(10\mathrm{g}\) hexane/AcOEt 5:1). The anomeric \(\alpha \beta\) ratio of disaccharide 11 was determined by HPLC analysis [eluent, hexane/THF 6:1; flow rate, \(1.5\mathrm{mLmin^{- 1}}\) ; detection, \(254~\mathrm{nm}\) . \(t_\mathrm{R}\) \(\beta\) anomer) \(= 15.2\mathrm{min}\) \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 16.9\mathrm{min}\) . The \(\alpha\) and \(\beta\) - glycosides were separated by preparative thin layer chromatography (hexane \(\mathrm{CH}_2\mathrm{Cl}_7\) acetone 20:20:1). Data for \(\alpha\) anomer 11a: \(R_{\mathrm{f}} = 0.56\) (hexane/AcOEt 2:1), 0.45 (hexane/ \(\mathrm{CHCl}_3\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{23} = 439.2\) \(c = 0.95\) in \(\mathrm{CHCl}_3\) [lit: \([\alpha ]_{\mathrm{D}}^{20} = +40\) \(c = 1.1\) in \(\mathrm{CHCl}_3\) )],[51] IR (film): \(\bar{\nu} =\) \(1062,3030,2925\) 2865,1730,1605,1496,1454,1361,1028,1157,1096, \(1050\mathrm{cm}^{- 1}\) 1H NMR \(\mathrm{(500MHz}\) \(\mathrm{CDCl}_3\) 4- 3.37 \((\mathrm{m},\mathrm{H};\mathrm{H} - 3,\mathrm{H};\mathrm{H};\) 1H; H- 6a)3.47- 3.50 m2H;H- 2H- 6b)3.59 (dd \(J = 3.4\) \(9.2\mathrm{Hz}\) 1H; H- 2)3.62- 3.66 m2H;H- 6aH- 4)3.70 (m1H;H- 5)3.81- 3.86 m 2H; H- 5, H- 6b)3.90 (dd, \(J = 8.6\mathrm{Hz}\) 1H; H- 7)4.04 (dd, \(J = 9.2\mathrm{Hz}\) 1H; H- 4)4.09t \(J = 9.2\mathrm{Hz}\) 1H;H- 3)4.27d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.41 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.49- 4.58 (m, 6H \(6\times \mathrm{OCHPh}\) 4.60 (d, \(J = 4.0\mathrm{Hz}\) 1H;H- 1)4.70d \(J = 12.6\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.77d \(J =\) \(10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.78 (d, \(J = 10.3\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.80 (d, \(J =\) \(11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.88d \(J = 10.3\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 5.03d \(J =\) \(11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 5.69d \(J = 3.4\mathrm{Hz}\) 1H;H- 1)7.08- 7.28 ppm (m, \(35\mathrm{H}\) aromatic). Data for \(\beta\) anomer 11: \(R_{\mathrm{f}} = 0.56\) hexane/AcOEt 2:1), 0.36 (hexane/ \(\mathrm{CHCl}_3\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{22} = +19.6\) \(c = 1.01\) in \(\mathrm{CHCl}_3\) [lit: \([\alpha ]_{\mathrm{D}}^{20} = +20\) \(c = 1.0\) in \(\mathrm{CHCl}_3\) )],[51] IR (film): \(\bar{\nu} = 3062\) 3030,2904, 1952,1874,1809,1730,1605,1586,1496,1453,1360,1044, \(911~\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{(500MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 3.29\) m, 1H; H- 5)3.35 (m, 1H; H- 2) 3.36 (s, 3H; \(\mathrm{OCH}_3\) 3.44- 3.49 (m, 3H; H- 2, H- 6a, H- 3)3.54 (dd, \(J = 4.6\) <|txt_contd|><|md_end|>
<|box_start|>514 081 922 173<|box_end|><|ref_start|>text<|ref_end|><|md_start|>\(11.5\mathrm{Hz}\) 1HH- 6a3.58m1HH- 53.60t \(J = 9.7\mathrm{Hz}\) 1HH- 4 3.71dd \(J = 1.7\) \(11.5\mathrm{Hz}\) 1H;H- 6b)3.61dd \(J = 3.4\) \(10.9\mathrm{Hz}\) 1H;H- 6b)3.84t \(J = 9.7\mathrm{Hz}\) 1H;H- 3)3.96t \(J = 9.7\mathrm{Hz}\) 1H;H- 4)4.36- 4.39 m3H;H- 12OCHPh4.43d \(J = 12.6\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.55d \(J = 10.3\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.56d \(J = 3.4\mathrm{Hz}\) 1HH- 14.57d \(J =\) \(10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.60d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.73- 4.81 m 6H \(6\times \mathrm{OCHPh}\) 4.86d \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 5.09d \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 7.17- 7.42 ppm (m, 35H; aromatic).<|md_end|>
<|box_start|>514 176 922 300<|box_end|><|ref_start|>text<|ref_end|><|md_start|>12: The glycosidation was performed according to the typical procedure \((1\mathrm{mL}\) dioxane \(\mathrm{Et}_2\mathrm{O}\) 1:1, \(0^\circ \mathrm{C}\) \(20\mathrm{min}\) employing diphenyl phosphate 1 \((77.3\mathrm{mg},0.10\mathrm{mmol})\) , alcohol 6 \((28.6\mathrm{mg},0.11\mathrm{mmol})\) \(\mathrm{HClO}_4\) \((0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) and pulverized 5- A M.S. \((50\mathrm{mg})\) An anomeric mixture of 1,2,3,4- di- isopropylidene- 6- O- (2,3,4,6- tetra- \(o\) benzyl- D- glucopyranosyl)- \(\alpha\) - D- galactopyranoside[52] (12; \(77.0\mathrm{mg}\) \(95\%\) \(\alpha /\beta = 89.11\) was obtained as a colorless oil from the crude product \((89.3\mathrm{mg})\) after column chromatography (silica gel \(10\mathrm{g}\) hexane/AcOEt 5:1). The anomeric \(\alpha /\beta\) ratio of disaccharide 12 was determined by HPLC analysis [eluent, hexane/THF 6:1; flow rate, \(1.5\mathrm{mLmin^{- 1}}\) ; detection, \(254~\mathrm{nm}\) . \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 11.3\mathrm{min}\) \(t_\mathrm{R}\) \(\beta\) anomer) \(= 12.5\mathrm{min}\) . The \(\alpha\) and \(\beta\) - glycosides were separated by preparative thin layer chromatography (hexane \(\mathrm{CH}_2\mathrm{Cl}_7\) acetone 20:20:1). Data for \(\alpha\) anomer 12a: \(R_{\mathrm{f}} = 0.59\) (hexane/AcOEt 2:1), 0.27 (hexane/ \(\mathrm{CHCl}_3\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{21} = +12.9\) \(c = 1.41\) in \(\mathrm{CHCl}_3\) [lit: \([\alpha ]_{\mathrm{D}}^{20} = +11\) \(c = 0.87\) in \(\mathrm{CHCl}_3\) )],[52a] IR (film): \(\bar{\nu} = 3063\) 3030,2987,2931,1496,1454,1382,1371,1255,1211,1165,1071, 1001, \(919\mathrm{cm^{- 1}}\) 1H NMR \(\mathrm{1500MHz}\) \(\mathrm{CHCl}_3\) \(d = 1.32\) s, 6H \(2\times \mathrm{CC}_4\mathrm{H}_3\) 1.46 (s, \(3\mathrm{H}\) \(\mathrm{CH}_2\mathrm{H}_3\) 1.54 (d, \(J = 3.5\mathrm{Hz}\) \(\mathrm{CH}_2\mathrm{H}_3\) 3.59 (dd, \(J = 4.0\) \(9.7\mathrm{Hz}\) 1H; H- 2)3.65 (dd \(J = 1.7\) 10.3 Hz1H;H- 6a)3.69t \(J = 9.7\mathrm{Hz}\) 1H;H- 4) 3.73- 3.80 (m, 3H; H- 6ab, H- 6b)3.83 (m, 1H; H- 5)3.99 (t, \(J = 9.7\mathrm{Hz}\) 1H; H- 3)4.05 (m, 1H; H- 5)4.32 (dd, \(J = 2.3\) \(5.2\mathrm{Hz}\) 1H; H- 2)4.36 (dd, \(J = 2.3\) 8.0 Hz,1H;H- 4)4.47 (d, \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.48 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.60 (dd, \(J = 2.3\) 8.0 Hz,1H; H- 3)4.63 (d, \(J =\) \(12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.70 \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.75 (d, \(J =\) \(12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.80 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.83 (d, \(J =\) \(10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.98 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 5.00 (d, \(J =\) \(4.0\mathrm{Hz}\) 1H;H- 1)5.52 (d, \(J = 5.2\mathrm{Hz}\) 1H;H- 1)7.13- 7.38 ppm (m, 20H; aromatic). Data for \(\beta\) anomer 12: \(R_{\mathrm{f}} = 0.59\) hexane/AcOEt 2:1),0.15 (hexane/ \(\mathrm{CHCl}_3\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{21} = 54.2\) \(\bar{\nu} = 0.22\) in \(\mathrm{CHCl}_3\) [lit: \([\alpha ]_{\mathrm{D}}^{21} = - 32.5\) \(c = 0.85\) in \(\mathrm{CHCl}_3\) )],[52a] IR (film): \(\bar{\nu} = 3090\) 3031,3010, 2911,2867,1717,1603,1496,1454,1384,1257,1069, \(1008~\mathrm{cm^{- 1}}\) 1H NMR \(\mathrm{(500MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 1.11\) s,6H \(2\times \mathrm{CC}_4\mathrm{H}_3\) 1.45 (s, 3H; \(\mathrm{CC}_4\mathrm{H}_3\) 1.50 (s, 3H; \(\mathrm{CC}_4\mathrm{H}_3\) 3.44- 3.48 (m, 2H; H- 2, H- 5)3.59- 3.65 (m, 2H; H- 3, H- 4)3.67- 3.75 (m, 3H; H- 6a, H- 6ab)4.09 (m, 1H; H- 5)4.16 (dd, \(J = 3.4\) 4.3, \(H_{- }1\mathrm{H}\) (6m, 2H; H- 24.4d, \(J = 2.3\) 8.0 Hz,1H; H- 4)4.32 (dd, \(J = 2.3\) \(5.2\mathrm{Hz}\) 1H; H- 2)4.45 (d, \(J = 8.0\mathrm{Hz}\) 1H; H- 1)4.50 (d, \(J = 10.3\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.53 (d, \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.59 (dd, \(J = 2.3\) \(8.0\mathrm{Hz}\) 1H; H- 3)4.61 (d, \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.72 (d, \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.77 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.81 (d, \(J = 10.3\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.96 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 5.05 (d, \(J = 11.1\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 5.57 (d, \(J = 5.2\mathrm{Hz}\) 1H; H- 1)7.12- 7.43 ppm (m, 20H; aromatic).<|md_end|>
<|box_start|>514 300 922 654<|box_end|><|ref_start|>text<|ref_end|><|md_start|>13: The glycosidation was performed according to the typical procedure \((1\mathrm{mL}\) dioxane \(\mathrm{Et}_2\mathrm{O}\) 1:1, \(0^\circ \mathrm{C}\) \(10\mathrm{min}\) preparing diphenyl phosphate 1 \((77.3\mathrm{mg},0.10\mathrm{mmol})\) ,olocanol 6 \((28.6\mathrm{mg},0.11\mathrm{mmol})\) \(\mathrm{HClO}_4\) \((0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) and pulverized 5- A M.S. \((50\mathrm{mg})\) An anomeric mixtureof 1,2,3,4- di- isopropylidene- 6- O- (2,3,4,6- tetra- \(o\) benzyl- D- glucopyranosyl)- \(\alpha\) - D- galactopyranoside[52] (12; \(77.0\mathrm{mg}\) \(95\%\) \(\alpha /\) \(\beta = 89.11\) was obtained as a colorless oil from the crude product \((89.3\mathrm{mg})\) after column chromatography (silica gel \(10\mathrm{g}\) hexane/AcOEt 5:1). The anomeric \(\alpha /\beta\) ratio of disaccharide 12 was determined by HPLC analysis [eluent, hexane/THF 6:1;flow rate, \(1.5\mathrm{mLmin^{- 1}}\) ;detection, \(254~\mathrm{nm}\) . \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 11.3\mathrm{min}\) \(t_\mathrm{R}\) \(\beta\) anomer) \(= 12.5\mathrm{min}\) . The \(\alpha\) and \(\beta\) - glycosides were separated by preparative thin layer chromatography (hexane/ \(\mathrm{CH}_2\mathrm{Cl}_7\) acetone 20:20:1). Data for \(\alpha\) anomer 12a: \(R_{\mathrm{f}} = 0.59\) (hexane/AcOEt 2:1), 0.27 (hexane/ \(\mathrm{CHCl}_3\) acetone 20:20:1) \([\alpha ]_{D}^{21} = +12.9\) \(c = 1.41\) in \(\mathrm{CHCl}_3\) [lit: \([\alpha ]_{\mathrm{D}}^{20} = +11\) \(c = 0.87\) in \(\mathrm{CHCl}_3\) )],[52a] IR (film): \(\bar{\nu} = 3063\) 30302987,2931,1496,1454,1382,1371,1255,1211,1165,1071, 1001, \(919\mathrm{cm^{- 1}}\) 1H NMR \(\mathrm{1500MHz}\) \(\mathrm{CHCl}_3\) \(d = 1\cdot 32\) s,6H \(2\times \mathrm{CC}_4\mathrm{H}_3\) 1.46 (s, 3H; \(\mathrm{CH}_2\mathrm{H}_3\) 1.54 (d, \(J = 2.3\) 8.0 Hz,1H; H- 3)4.05 (d, \(J = 8.0\mathrm{Hz}\) 1H; H- 2)4.36 (dd, \(J = 2.3\) 8.0 Hz,1H; H- 4)4.47 (d, \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.48 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.60 (dd, \(J = 2.3\) 8.0 Hz,1H; H \(^{- }3\) 4.63 (d, \(J =\) \(12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.70 \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.75 (d, \(J =\) \(12.0\mathrm{Hz}\) 1H \(\mathrm{OCHph}_3\) 4.80 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHph}_3\) 4.83 (d, \(J =\) \(10.9\mathrm{Hz}\) 1H \(\mathrm{OCHph}_3\) 4.98 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHph}_3\) 5.00 (d, \(J =\) \(4.0\mathrm{Hz}\) 1H; H- 1)5.52 (d, \(J = 5.2\mathrm{Hz}\) 1H; H- 1)7.13- 7.38 ppm (m, 20H; aromatic). Data for \(\beta\) anomer 12: \(R_{\mathrm{f}} = 0.59\) hexane/AcOEt 2:1),0.15 (hexane/ \(\mathrm{CHCl}_3\) acetone 20:20:1) \([\alpha ]_{\mathrm{Dr}}^{21} = 54.2\) \(\bar{\nu} = 0.22\) in \(\mathrm{CHCl}_3\) [lit: \([\alpha ]_{\mathrm{D}}^{21} = - 32.5\) \(c = 0.85\) in \(\mathrm{CHCl}_3\) )],[52a] IR (film): \(\bar{\nu} = 30\mathrm{90}\) 3031,3010, 2911,2867,1717,1603,1496,1454,1384,1257,1069, \(1008~\mathrm{cm^{- 1}}\) 1H NMR \(\mathrm{(500MHz}\) \(\mathrm{CDCl}_3\) \(\delta \mathrm{= 1.11}\) s,6H \(2\times \mathrm{CC}_4\mathrm{H}_3\) 1.45 (s, 3H; \(\mathrm{CC}_4\mathrm{H}_3\) 1.50 (s, 3H; \(\mathrm{CC}_4\mathrm{H}_3\) 3.44- 3.48 (m, 2H; H- 2, H- 7)3.59- 3.65 (m, 2H; H- 3, H- 4)4.367- 3.75 (m, 3H; H- 6a, H- 6b)4.09 (m, 1H; H- 5)4.16 (dd, \(J = 3.4\) 4.3, \(H_{- }1\mathrm{H}\) (6m, 2H; H- 24.4d, \(J = 2.3\) 8.0 Hz,1H; H- 4)4.42 (dd, \(J = 2.3\) \(5.2\mathrm{Hz}\) 1H; H- 2)4.45 (d, \(J = 8.0\mathrm{Hz}\) 1H; H- 1)4.50 (d, \(J = 10.3\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.53 d \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.59 (dd, \(J = 2.3\) 8.0 Hz, 1H; H- 3)4.61 (d, \(J = 12.0\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.72 (d, \(J = 11.5\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.77 (d, \(J = 10.9\mathrm{Hz}\)\(\mathrm{CHCl}_3\) 4.81 (d, \(J = 10.3\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 4.96 (d, \(J = 10.9\mathrm{Hz}\) 1H \(\mathrm{OCHPh}_3\) 5.05 (d, \(J = 11.1\mathrm{Hz}\) 1H \({\mathrm{OCHPh}}_3\) 5.57 (d, \(J = 5.2\mathrm{Hz}\) 1H; H- 1)7.12- 7.43 ppm (m, 20H; aromatic).<|md_end|>
<|box_start|>514 657 922 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>13: The glycosidation was performed according to the typical procedure \((1\mathrm{mL}\) dioxane \(\mathrm{Et}_2\mathrm{O}\) 1:1, \(0^\circ \mathrm{C}\) \(10\mathrm{min}\) ) preparing diphenyl phosphate 1 \((77.3\mathrm{mg},0.10\mathrm{mmol})\) ,olocanol 6 \((28.6\mathrm{mg},0.11\mathrm{mmol})\) \(\mathrm{HClO}_4\) \((0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.0\bar{0} 5\mathrm{mmol}\) and pulverized 5- A M.S. \((50\mathrm{mg})\) An anomeric mixture of benzyl- 2,3- anhydro- 0- (2,3,4,6- tetra- 0- benzyl- D- glucopyranosyl)- \(\beta\) - D- ribopyranoside[53] (13; \(62.8\mathrm{mg}\) \(85\%\) \(\alpha /\beta = 86.14\) was obtained as a colorless oil from the crude product \((79.3\mathrm{mg})\) after column chromatography (silica gel \(10\mathrm{g}\) hexane/AcOEt 5:1). The anomeric \(\alpha /\beta\) ratio of glucoside 13 was determined by HPLC analysis [eluent, hexane/AcOEt 20:1; flow rate, \(1.5\mathrm{mLmin^{- 1}}\) ;detection, \(254~\mathrm{nm}\) . \(t_\mathrm{R}\) \(\beta\) a- nomeric) \(= 6.5\mathrm{min}\) \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 14.9\mathrm{min}\) . The \(\alpha\) and \(\beta\) - glycosides were separated by preparative thin layer chromatography (hexane/ \(\mathrm{CH}_2\mathrm{Cl}_7\) acetone 10:10:1). Data for \(\alpha\) anomer 13a: \(R_{\mathrm{f}} = 0.56\) hexane/AcOEt 2:1),0.20 (hexane/ \(\mathrm{CHCl}_3\) acetone 20:20:1) \([\alpha ]_{\mathrm{Dr}}^{21} = +44.3\) \(c = 0.36\) in \(\mathrm{CHCl}_3\) [lit: \([\alpha ]_{\mathrm{Dr}}^{25} = +44\) \(c = 1.2\) in \(\mathrm{CHCl}_3\) )],[53] IR \(\mathrm{(CHCl}_3\) \(\bar{\nu} = 3130\) 2926,2868,1496,1454,1362,1140,1088,1069, \(1027~\mathrm{cm^{- 1}}\) 1H NMR \(\mathrm{(500MHz}\) \(\mathrm{CDCl}_3\) \(d = 3.28\) (d, \(J = 4.0\mathrm{Hz}\) 1H; H- 2)3.48- 3.51 (m, 2H; H- 3, H- 5a)3.58- 3.65 (m, 3H; H- 2, H- 4, H- 6a)3.70 (dd, \(J = 3.4\) \(10.9\mathrm{Hz}\) 1H; H- 6b)3.78 (m, 1H; H- 5)3.83 (dd, \(J = 4.6\) \(12.0\mathrm{Hz}\) 1H;<|md_end|>
--------------------------------------------------
<|box_start|>076 081 484 298<|box_end|><|ref_start|>text<|ref_end|><|md_start|>H- 5b),4.00- 4.06 m2H;H- 4H- 34.45d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh) 4.46d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh4.58d \(J = 11.2 \mathrm{Hz}\) 1H;OCHPh) 4.59d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh4.72d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh) 4.77- 4.85 m4H \(4\times \mathrm{OCHPh}\) 5.011d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh5.014 s,1HH- 15.11d \(J = 3.4 \mathrm{Hz}\) 1HH- 17.12- 7.41ppm \((\mathrm{m},25\mathrm{H}\) aromatic).Data for \(\beta\) anomer \(\mathbf{13}\beta\) . \(R_{\mathrm{f}} = 0.56\) hexane/AcOEt 2:1)0.19 (hexane/CHCl/acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{22} = +6.0\) \((c = 0.91\) in \(\mathrm{CHCl}_3\) [lit. \([\alpha ]_{\mathrm{D}}^{22} = +6\) \(c = 1.0\) in \(\mathrm{CHCl}_3\) )[53] IR \(\mathrm{CHCl}_3\) \(\bar{\nu} = 3089\) 3066,3032,3012, 2914,2870,1952,1731,1496,1454,1360,1069, \(1027~\mathrm{cm^{- 1}}\) H NMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_2\) \(\delta = 3.25\) d \(J = 4.0 \mathrm{Hz}\) 1HH- 5.50m1H \(\mathrm{H} - 5^{\prime}\) \(3.53 - 3.58\) m3H;H- 5aH- 2H- 3 \(3.60\) t \(J = 4.0 \mathrm{Hz}\) 1HH- 33.63- \(3.67(\mathrm{m},2\mathrm{H};\mathrm{H} - 4^{\prime},\mathrm{H} - 6\mathrm{a})\) 3.72dd \(J = 1.7\) \(10.9 \mathrm{Hz}\) 1HH- 6b3.84dd \(J = 4.6\) 12.0 Hz1HH- 5.40 \((\mathrm{m},1\mathrm{H};\mathrm{H}^{- 1})\) 4.52d \(J = 8.0 \mathrm{Hz}\) 1H H- 14,4.54d \(J = 12.7 \mathrm{Hz}\) 1H;OCHPh)4.55d \(J = 10.7 \mathrm{Hz}\) 1H; OCHPh)4.58d \(J = 12.7 \mathrm{Hz}\) 1H;OCHPh4.59d \(J = 11.5 \mathrm{Hz}\) 1H; OCHPh)4.73d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh4.79d \(J = 10.9 \mathrm{Hz}\) 1H; OCHPh)4.81- 4.83m2H \(2\times \mathrm{OCHPh}\) 4.93d \(J = 10.9 \mathrm{Hz}\) 1H; OCHPh)4.96d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)5.02s,1HH- 17,7.17- \(7.38\mathrm{ppm}\) m25H;aromatic).<|md_end|>
<|box_start|>076 302 484 722<|box_end|><|ref_start|>text<|ref_end|><|md_start|>14: The glycosidation was performed according to the typical procedure \(1\mathrm{mL}\) dioxane/EtO 1:1, \(0^\circ \mathrm{C}\) \(20\mathrm{min}\) employing diphenyl phosphate 1 \((77.3\mathrm{mg}\) \(0.10\mathrm{mmol}\) ),cholesterol (8 \(42.5\mathrm{mg}\) \(0.11\mathrm{mmol}\) \(\mathrm{HCIO_4}\) \(0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) and pulverized \(5 - \mathrm{\AA}\) M.S. \((50~\mathrm{mg})\) .An anomeric mixture of cholesteryl 2,3,4,6- tetra- \(o\) - benzyl- D- glucopyranoside[54] 14 \(85.6\mathrm{mg}\) \(94\%\) \(\alpha /\beta = 89.11\) was obtained as a white silica from the crude product (101.6 mg) after column chromatography (silica gel \(10\mathrm{g}\) \(\mathrm{CH}_2\mathrm{Cl}_2/\) hexane 5:1). The anomeric \(\alpha \beta\) ratio of glucoside 14 was determined by HPLC analysis [eluent, hexane/AcOEt 20:1; flow rate, \(1.0\mathrm{mLmin^{- 1}}\) detection, \(254~\mathrm{nm}\) . \(t_\mathrm{R}\) \(\beta\) anomer) \(= 26.7 \mathrm{min}\) \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 41.1\mathrm{min}]\) .The \(\alpha\) and \(\beta\) glycosides were separated by flash column chromatography with \(\mathrm{CH}_2\mathrm{Cl}_2/\) hexane (4:1). Data for \(\alpha\) anomer 14c: \(R_{\mathrm{f}} = 0.40\) \(\mathrm{CH}_2\mathrm{Cl}_2/\) hexane 5:1) \([\alpha ]_{\mathrm{D}}^{20} = +45.4\) in \(+1.00\) in \(\mathrm{CHCl}_3\) [lit. \([\alpha ]_{\mathrm{D}}^{20} = +46.0\) \(c = 1.5\) in \(\mathrm{CHCl}_3\) )[5ab] IR (KBr) \(\bar{\nu} = 3027\) 2932,2866,1496, 1454, 1375, 1165, 1052, 753, 732, \(698~\mathrm{cm^{- 1}}\) 1HNMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_2\) \(\delta = 0.68\) s,3HH- 18)0.86- 1.60 m33H1.79- 1.88 m3H1.95 m1H)2.02 m1H2.27 m1HH- 4a2.43 m1HH- 4b3.48 m 1H;H- 5)3.53dd \(J = 4.0\) 9.2 Hz1HH- 2)3.62- 3.66 m2H;H- 4H6a)3.74dd \(J = 3.4\) 10.9 Hz1H;H- 6b3.86- 3.89 m1H;H- 54.00 t \(J = 9.2 \mathrm{Hz}\) 1HH- 34.45d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh)4.46d \(J =\) \(10.9\mathrm{Hz}\) 1H;OCHPh)4.61d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh)4.65d \(J =\) \(12.0\mathrm{Hz}\) 1H;OCHPh4.77d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh4.82d \(J =\) \(10.9\mathrm{Hz}\) 1H;OCHPh)4.83d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)4.93d \(J =\) \(4.0 \mathrm{Hz}\) 1H;H- 1)5.01d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)5.29 m,1H;H- 6, \(7.12 - 7.37\mathrm{ppm}\) m201d-aromatic).Data for \(\beta\) anomer 14f \(R_{\mathrm{f}} = 0.22\) \(\mathrm{(CH_2Cl_2 / }\) hexane 5:1) \([\alpha ]_{\mathrm{D}}^{21} = +1.6\) \(c = 0.33\) in \(\mathrm{CHCl}_3\) [lit. \([\alpha ]_{\mathrm{D}}^{20} = +0.2\) \(c = 1.6\) in \(\mathrm{CHCl}_3\) )[5sb] IR \(\mathrm{(CHCl_3)}\) \(\bar{\nu} = 3032\) 2942,2868,1490,1455, 1362, 1292, 1068, 1011, \(966~\mathrm{cm^{- 1}}\) 1HNMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_2\) \(\delta = 0.68\) s, 3H;H- 18)0.86- 1.71 m33H)1.79- 1.87 m2H)1.96- 2.03 m3H) 2.34 m1H;H- 4a)2.41 m1H;H- 4b)3.43- 3.47 m2H;H- 2H- 6a) 3.54 t \(J = 9.2 \mathrm{Hz}\) 1HH- 33.57- 3.66 m3HH- 3H4H- 4H- 5)3.73 dd \(J = 1.7\) \(10.9 \mathrm{Hz}\) 1H;H- 6b)4.50d \(J = 8.1 \mathrm{Hz}\) 1H;H- 1)4.53d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)4.55d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh)4.60d \(J =\) \(12.0\mathrm{Hz}\) 1H;OCHPh)4.72d \(J = 10.8 \mathrm{Hz}\) 1H;OCHPh)4.78d \(J =\) \(10.9\mathrm{Hz}\) 1H;OCHPh)4.81d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)4.92d \(J =\) \(10.9\mathrm{Hz}\) 1H;OCHPh)4.97d \(J = 10.8 \mathrm{Hz}\) 1H;OCHPh)5.35 m1H; H- 6)7.16- 7.36 ppm m20H;aromatic).<|md_end|>
<|box_start|>076 725 484 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>15: The glycosidation was performed according to the typical procedure \(1\mathrm{mL}\) dioxane/EtO 1:1, \(0^\circ \mathrm{C}\) \(30\mathrm{min}\) employing diphenyl phosphate 1 \(77.3\mathrm{mg}\) \(0.10\mathrm{mmol}\) 1- adamantanol 9 \(1.7\mathrm{mg}\) \(0.11\mathrm{mmol}\) \(\mathrm{HCIO_4}\) \(0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) and pulverized \(5 - \mathrm{\AA}\) M.S. \((50~\mathrm{mg})\) .An anomeric mixture f1- adamantanyl 2,3,4,6- tetra- \(o\) - benzyl- Dglucopyranoside[55] (15; \(58.3\mathrm{mg}\) \(86\%\) \(\alpha /\beta = 87:13\) was obtained as a colorless oil from the crude product \((103.7\mathrm{mg})\) after column chromatography (silica gel \(10\mathrm{g}\) hexane/AcOEt 5:1). The anomeric \(\alpha /\beta\) ratio of glucoside 15 was determined by HPLC analysis [eluent, hexane/THF 6:1; flow rate, \(1.0\mathrm{mLmin^{- 1}}\) ;detection, \(254~\mathrm{nm}\) . \(t_\mathrm{R}\) \(\beta\) anomer) \(= 6.41 \mathrm{min}\) \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 6.97\mathrm{min}]\) .The \(\alpha\) and \(\beta\) glycosides were separated by flash column chromatography with \(\mathrm{CH}_2\mathrm{Cl}_2/\) hexane (20:1). Data for \(\alpha\) anomer 15a: \(R_{\mathrm{f}} = 0.60\) (hexane/AcOEt 2:1)0.37 \(\mathrm{(CH_2Cl_2)}\) \([\alpha ]_{\mathrm{D}}^{23} = +45.3\) \(c = 0.98\) <|txt_contd|><|md_end|>
<|box_start|>515 081 922 331<|box_end|><|ref_start|>text<|ref_end|><|md_start|>in \(\mathrm{CHCl}_3\) IR (film) \(\bar{\nu} = 3063\) 3006,2852,1869,1728,1586,1453,1315, 1268,1186,1073,983,908,814, \(734~\mathrm{cm^{- 1}}\) . \({}^{1}\mathrm{H}\) NMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_3\) 1 \(\delta = 1.57 - 1.64\) m6H \(3\times \mathrm{CH}_2\) 1.79- 1.85 m6H \(3\times \mathrm{CH}_2\) 2.10- 2.16 m 3H \(3\times \mathrm{CH}_2\) 3.53dd \(J = 1.4\) 9.7 Hz1HH- 23.61dd \(J = 1.7\) \(10.3\mathrm{Hz}\) 1H;H- 5)3.65dd \(J = 1.7\) \(9.2\mathrm{Hz}\) 1H;H- 6a3.76dd \(J = 3.4\) \(10.3\mathrm{Hz}\) 1HH- 4)3.99- 4.03 m2H;H- 3H- 6b)4.45d \(J = 12.0 \mathrm{Hz}\) 1H; OCHPh)4.46d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)4.62- 4.71 m3H \(3\times\) OCHPh)4.80d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)4.83d \(J = 10.3 \mathrm{Hz}\) 1H; OCHPh)4.99d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)5.27d \(J = 3.4 \mathrm{Hz}\) 1H 1)7.12- 7.36 ppm \((20\mathrm{H}\) n, ananatic).Data for \(\beta\) anomer 15f: \(R_{\mathrm{f}} = 0.53\) (hexane/AcOEt 2:1)0.18 \(\mathrm{(CH_2Cl_2)}\) \([\alpha ]_{\mathrm{D}}^{23} = +14.2\) \(c = 0.96\) in \(\mathrm{CHCl}_3\) [lit. \([\alpha ]_{\mathrm{D}}^{23} = +14.1\) \(c = 6.1\) in \(\mathrm{CHCl}_3\) )[55a] IR (film) \(\bar{\nu} = 3088\) 3026,2830, 2807,1947,1817, \(1604\) 1454,1363,1318,1278,1229)1209,1165,1032, 940,907,841 \(753~\mathrm{cm^{- 1}}\) 1HNMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 1.60 - 1.66\) m, 1H; \(3\times \mathrm{CH}_2\) 1.72 \(1.95\mathrm{cm^{- 1}}\) . \(\alpha /\beta = 14.2:2.18\) \((\alpha = 2.12 - 3.25)\) 3.43 (dd, \(J = 5.7\) \(8.6\mathrm{Hz}\) 1H;H- 2)3.47 m1H;H- 5)3.50dd \(J = 5.2\) \(9.7\mathrm{Hz}\) 1H;H- 4)3.60 (m1H;H- 6a)3.64 (dd \(J = 5.2\) \(8.6\mathrm{Hz}\) 1H;H- 5)3.73 (br d \(J = 10.9 \mathrm{Hz}\) 1H;H- 6b)4.53- 4.60 m3H \(3\times \mathrm{OCHPh}\) 4.69 \(\mathrm{d},J = 5.7 \mathrm{Hz}\) 1H;H- 1)5.71 d \(J = 9.2 \mathrm{Hz}\) 1H;OCHPh)4.77 d \(J =\) \(10.8\mathrm{Hz}\) 1H;OCHPh)4.82d \(J = 10.8 \mathrm{Hz}\) 1H;OCHPh)7.18- 7.36 ppm \((20\mathrm{H}\) m, anomatic).<|md_end|>
<|box_start|>515 334 922 722<|box_end|><|ref_start|>text<|ref_end|><|md_start|>16: The glycosidation was performed according to the typical procedure \(1\mathrm{mL}\) dioxane/EtO 1:1, \(0^\circ \mathrm{C}\) \(20\mathrm{min}\) employing diphenyl phosphate 1 \(77.3\mathrm{mg}\) \(0.10\mathrm{mmol}\) 1- methylthocyanophenol (10; \(13.7\mathrm{mg}\) \(0.11\mathrm{mmol}\) \(\mathrm{HCIO_4}\) \((0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) and pulverized \(5 - \mathrm{\AA}\) M.S. \((50~\mathrm{mg})\) .An anomeric mixture of 4- methoxyphenyl 2,3,4,6- tetra- \(o\) benzyl- D- glucopyranoside[59] 16: \(55.1\mathrm{mg}\) \(85\%\) \(\alpha /\beta = 85:15\) was obtained as a colorless oil from the crude product \((69.0\mathrm{mg})\) after column chromatography (silica gel \(10\mathrm{g}\) hexane/AcOEt 6:1). The anomeric \(\alpha /\beta\) ratio of glucoside 16 was determined by HPLC analysis [eluent, hexane/ AcOEt 10:1; flow rate, \(1.5\mathrm{mLmin^{- 1}}\) ;detection, \(254~\mathrm{nm}\) . \(t_\mathrm{R}\) \(\beta\) anomer) \(= 17.7\mathrm{min}\) \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 19.9 \mathrm{min}]\) .The \(\alpha\) and \(\beta\) glycosides were separated by preparative thin layer chromatography (hexane/ \(\mathrm{CH}_2\mathrm{Cl}_2/\) acetone 20:20:1).Data for \(\alpha\) anomer 16a: \(R_{\mathrm{f}} = 0.69\) hexane/AcOEt 2:1)0.63 (hexane/ \(\mathrm{CHCl}_3/\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{23} = +9.13\) \(c = 1.35\) in \(\mathrm{CHCl}_3\) [lit. \([\alpha ]_{\mathrm{D}}^{23} = +92\) \(\mathrm{C} = 1.0\) in \(\mathrm{CHCl}_3\) )[59] \(\alpha /\beta = 5062\) 5050,2928,2865, 1588,1507,1453,1361,1214,1073,1031, \(827~\mathrm{cm^{- 1}}\) . \({}^{1}\mathrm{H}\) NMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 3.59\) (dd \(J = 11.7\) \(10.9 \mathrm{Hz}\) 1H;H- 6a)3.67- 3.77 m3H;H- 2, H- 4,H- 6b)3.77 s \(3\mathrm{H}\) \(\mathrm{OCl}_3\) )3.92 m1HH- 5)4.18 t \(J = 9.2 \mathrm{Hz}\) 1H;H- 3)4.41 d \(J = 11.1 \mathrm{Hz}\) 1H;OCHPh)4.49 d \(J = 10.9 \mathrm{Hz}\) 1H; \(\mathrm{OHPh}\) 4.59d \(J = 11.5 \mathrm{Hz}\) 1H;OCHPh)4.69 d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh)4.80d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh)4.86 d \(J = 10.9 \mathrm{Hz}\) 1H; OCHPh)4.88 d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)5.05 d \(J = 10.9 \mathrm{Hz}\) 1H; OCHPh)5.36 d \(J = 3.4\mathrm{Hz}\) 1H;H- 1)6.78- 6.82 m2H;aromatic) \(7.00 - 7.03\) m2H;aromatic)7.13- 7.39 ppm m20H;aromatic).Data for \(\beta\) anomer 16b: \(R_{\mathrm{f}} = 0.69\) hexane/AcOEt 2:1)0.56 hexane/ \(\mathrm{CHCl}_3/\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{23} = - 5.1\) \(c = 0.41\) in \(\mathrm{CHCl}_3\) [lit. \([\alpha ]_{\mathrm{D}}^{23} = - 4\) \(c = 1.0\) in \(\mathrm{CHCl}_3\) )[59] IR (film) \(\bar{\nu} = 3033\) 3011,2911,2868,1507,1454,1360, 1211,1068,1029, \(828~\mathrm{cm^{- 1}}\) . \({}^{1}\mathrm{H}\) NMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 3.58\) m1H H- 5)3.64- 3.73 m4H;H- 2,H- 3,H- 4,H- 6a)3.78 s3H; \(\mathrm{OCH}_3\) )3.79 m1H;H- 6b)4.54 d \(J = 12.0 \mathrm{Hz}\) 1H;OCHPh)4.57 d \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)4.60 d \(J = 10.0 \mathrm{Hz}\) 1H;OCHPh)4.81- 4.86 m3H \(3\times\) OCHPh)4.88 (dd, \(J = 2.3\) 5.10 Hz1H;H- 1)4.95 d \(J = 10.9 \mathrm{Hz}\) 1H; OCHPh)5.05 (d, \(J = 10.9 \mathrm{Hz}\) 1H;OCHPh)6.79- 6.83 m2H; aromatic),7.02- 7.05 (m,2H;aromatic),7.18- 7.47 ppm m20H;aromatic).<|md_end|>
<|box_start|>515 725 922 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>23: The glycosidation was performed according to the typical procedure \(0.5\mathrm{mL}\) dioxane/EtO 1:1, \(0^\circ \mathrm{C}\) \(5\mathrm{min}\) employing galactosyl diphenyl phosphate 17 \(38.6\mathrm{mg}\) \(0.05\mathrm{mmol}\) alcohol 3 \(25.6\mathrm{mg}\) \(0.055\mathrm{mmol}\) \(\mathrm{HCIO_4}\) \(0.1\mathrm{M}\) in dioxane, \(0.025~\mathrm{mL}\) \(0.0025\mathrm{mmol}\) and pulverized \(5 - \mathrm{\AA}\) M.S. \((25~\mathrm{mg})\) .An anomeric mixture of methyl 2,3,4- tri- \(o\) - benzyl- 6- O- (2,3,4,6- tetra- \(o\) - benzyl- D- galactopyranosyl)- \(\alpha\) - D- glucopyranoside[9] (23; \(43.6\mathrm{mg}\) \(88\%\) \(\alpha /\beta = 75:25^{\circ}\) was obtained as a colorless oil from the crude product \((60.1\mathrm{mg})\) after column chromatography (silica gel \(8\mathrm{g}\) hexane/ AcOEt 5:1). The anomeric \(\alpha /\beta\) ratio of disaccharide 23 was determined by HPLC analysis [eluent, hexane/THF 4:1; flow rate, \(1.5\mathrm{mLmin^{- 1}}\) ;de- tection, \(254~\mathrm{nm}\) . \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 14.5 \mathrm{min}\) \(t_\mathrm{R}\) \(\beta\) anomer) \(= 16.7 \mathrm{min}\) .The \(\alpha\) and \(\beta\) - glycosides were separated by preparative thin layer chromatography (hexane/ \(\mathrm{CH}_2\mathrm{Cl}_2/\) acetone 20:20:1). Data for \(\alpha\) anomer \(23\alpha\) . \(R_{\mathrm{f}} =\)<|md_end|>
--------------------------------------------------
<|box_start|>076 082 484 356<|box_end|><|ref_start|>text<|ref_end|><|md_start|>0.53 (hexane/AcOEt 2:1), 0.38 (hexane/CHCl/acetone 20:20:1); \([\alpha ]_{\mathrm{D}}^{33} =\) \(+51.9\) \(c = 1.04\) in \(\mathrm{CHCl}_2\) [lit.: \([\alpha ]_{\mathrm{D}}^{33} = +51\) \(c = 1.3\) in \(\mathrm{CHCl}_2\) [10: IR (film): \(\bar{\nu} = 3011\) 29271724149614541360116010951028 \(\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{(400~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 3.25\) 5H \(\mathrm{OC}H_{3}\) 3.41dd \(J = 3.2\) \(9.5\mathrm{Hz}\) 1H H- 23.46- 3.53m2HH- 6ab3.58t \(J = 9.5\mathrm{Hz}\) 1HH- 43.71- 3.81 m3HH- 5H- 6ab3.89- 3.99m4HH- 3H- 3H- 4H- 54.03dd \(J = 3.2\) \(9.5\mathrm{Hz}\) 1H \(\mathrm{H}^{- 2}\) 4.36d \(J = 11.8\mathrm{Hz}\) 1H;OCHPh4.43d \(J =\) 11.8 Hz, 1H;OCHPh4.52d \(J = 3.2\mathrm{Hz}\) 1HH- 14.54- 4.59m3H \(3\times \mathrm{OC}H\mathrm{Ph}\) 4.67- 4.75m4H \(4\times \mathrm{OC}H\mathrm{Ph}\) 4.79d \(J = 12.2\mathrm{Hz}\) 1H; OCHPh4.80d \(J = 10.9\mathrm{Hz}\) 1H;OCHPh4.83d \(J = 10.9\mathrm{Hz}\) 1H; OCHPh4.94d \(J = 11.3\mathrm{Hz}\) 1H;OCHPh4.96d \(J = 10.9\mathrm{Hz}\) 1H OCHPh4.99d \(J = 3.2\mathrm{Hz}\) 1HH- 17.13 \(7.28\mathrm{ppm}\) m35H;aromatic).Data for \(\beta\) anomer 23 \(\mathrm{R}_i = 0.53\) hexane/AcOEt 2:1) [lit.: hexane/ \(\mathrm{CHCl}_2/\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{32} = +12.6\) \((c = 0.46\) in \(\mathrm{CHCl}_2\) [lit.: \([\alpha ]_{\mathrm{D}}^{32} =\) \(+12.6\) \((c = 1.0\) in \(\mathrm{CHCl}_2\) [9] IR (film: \(\bar{\epsilon} = 3011\) 2929172914961454 13601281107 \(\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{(400~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 3.29\) 3H; \(\mathrm{OCH}_3\) 3.46t \(J = 9.5\mathrm{Hz}\) 1HH- 43.47- 3.62m6HH- 2H- 6aH- 3 H- 5H- 6ab3.81m1HH- 53.84t \(J = 7.7\mathrm{Hz}\) 1HH- 23.97t \(J = 9.5\mathrm{Hz}\) 1HH- 34.14dd \(J = 1.8\) 10.4 Hz1HH- 6b4.30d \(J =\) \(7.7\mathrm{Hz}\) 1HH- 14.39d \(J = 11.8\mathrm{Hz}\) 1H;OCHPh4.43d \(J = 11.8\mathrm{Hz}\) 1H;OCHPh4.50d \(J = 11.3\mathrm{Hz}\) 1H;OCHPh4.56d \(J = 11.8\mathrm{Hz}\) 1H;OCHPh4.57d \(J = 3.2\mathrm{Hz}\) 1HH- 184.64d \(J = 12.2\mathrm{Hz}\) 1H; OCHPh4.69- 4.72m3H \(3\times \mathrm{OC}H\mathrm{Ph}\) 4.76- 4.79m3H \(3\times \mathrm{OC}H\mathrm{Ph}\) 4.91- 4.97m3H \(3\times \mathrm{OC}H\mathrm{Ph}\) 7.15- 7.35 ppm (m \(35\mathrm{H}\) ;aromatic).<|md_end|>
<|box_start|>075 358 484 827<|box_end|><|ref_start|>text<|ref_end|><|md_start|>24: The glycosidation was performed according to the typical procedure \((1\mathrm{mL}\) dioxane \(/\mathrm{Et}_2\mathrm{O}\) 1:1, \(0^\circ \mathrm{C}\) 5 min) employing diphenyl phosphate 17 \((77.3\mathrm{mg},0.10\mathrm{mmol})\) , alcohol 5 \((51.1\mathrm{mg},0.11\mathrm{mmol})\) \(\mathrm{HCIO_4}\) \((0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) and pulverized \(5 - \mathrm{\AA}\) M.S. \((50\mathrm{mg})\) .An anomeric mixture of methyl 2,3,6- tri- \(o\) - benzyl- 4- O- (2,3,4,6- tetra- Obenzyl- D- galactopyranosyl)- \(\mathbb{C}\) D- glucopyranoside[9,57] (24) \(75.6\mathrm{mg}\) \(77\%\) \(\alpha /\beta = 90:10\) was obtained as a colorless oil from the crude product \((136.1\mathrm{mg})\) after column chromatography (silica gel \(10\mathrm{g}\) hexane/AcOEt 5:1). The anomeric \(\alpha /\beta\) ratio of disaccharide 24 was determined by HPLC analysis [eluent, hexane/THF 6:1; flow rate, \(0.5\mathrm{mL}\mathrm{min}^{- 1}\) ;detection, \(254~\mathrm{mm}\) . \(t_\mathrm{R}\) \(\beta\) anomer) \(= 50.9\mathrm{min}\) \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 52.4\mathrm{min}\) .The \(\alpha\) and \(\beta\) - glycosides were separated by preparative thin layer chromatography (hexane \(/\mathrm{CH}_2\mathrm{Cl}_2\) acetone 20:20:1).Data for \(\alpha\) - anomer 24: \(R_{\mathrm{f}} = 0.53\) (hexane/AcOEt 2:1), 0.42 (hexane/ \(\mathrm{CHCl}_2\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{32} = +37.0\) \(c = 0.52\) in \(\mathrm{CHCl}_2\) [lit.: \([\alpha ]_{\mathrm{D}}^{32} = +33\) \(c = 1.3\) in \(\mathrm{CHCl}_2\) [9] IR (film): \(\bar{\nu} =\) 3132, 3010, 2928, 1722, 1496, 1454, 1360, 1279, 1095, \(1046~\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 3.37\) s1H; \(\mathrm{OCH}_3\) 3.39- 3.49m2HH- 6ab 3.55dd \(J = 3.2\) \(9.5\mathrm{Hz}\) 1HH- 23.64dd \(J = 2.3\) 10.9 Hz1H H- 6a 3.70dd \(J = 4.1\) \(10.9\mathrm{Hz}\) 1HH- 6b3.81dd \(J = 2.0\) \(10.0\mathrm{Hz}\) 1H;H- 3H 3.84- 3.88m2HH- 5H- 53.93m1H \(\mathrm{H}^{- 4}\) 3.96- 4.00m3H H- 4H- 24.07t \(J = 9.5\mathrm{Hz}\) 1HH- 34.22d \(J = 11.3\mathrm{Hz}\) 1H; OCHPh4.29d \(J = 11.3\mathrm{Hz}\) 1H;OCHPh4.41d \(J = 12.2\mathrm{Hz}\) 1H; OCHPh4.51- 4.57m4HH- 1 \(3\times \mathrm{OC}H\mathrm{Ph}\) 4.60d \(J = 12.2\mathrm{Hz}\) 1H; OCHPh4.65- 4.71m4H \(4\times \mathrm{OC}H\mathrm{Ph}\) 4.81d \(J = 11.8\mathrm{Hz}\) 1H; OCHPh4.86d \(J = 11.3\mathrm{Hz}\) 1H;OCHPh4.97d \(J = 11.8\mathrm{Hz}\) 1H; OCHPh5.76d \(J = 3.6\mathrm{Hz}\) 1HH- 17.17- 3.31 ppm (m35H;aromatic).Data for \(\beta\) anomer 24B: \(R_{\mathrm{f}} = 0.53\) hexane/AcOEt 2:1), 0.36 (hexane/ \(\mathrm{CHCl}_2/\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{32} = +10.5\) \(c = 0.75\) in \(\mathrm{CHCl}_2\) [lit.: \([\alpha ]_{\mathrm{D}}^{20 + 2} =\) \(+10\) \(c = 1\) in \(\mathrm{CHCl}_2\) [57] (film) \(\bar{\nu} = 300.2\) 2020,2918,2867,1953, 1875, 1811, 1605, 1496, 1454, 1363, 1097, 910, 907, 916, 908, 500 MHz, \(\mathrm{CDCl}_3\) \(\delta = 3.29 - 3.36\) m34H3H- 3H5H- 6a3.36s1H \(\mathrm{OCH}_3\) 3.46dd \(J = 3.4\) 9.7 Hz1HH- 23.49m1HH- 6a3.53s1 \(J = 8.6\mathrm{Hz}\) 1HH- 63.59m1HH- 53.73dd \(J = 7.4\) 9.7 Hz1HH- 23.79- 3.83m2HH- 3H- 63.88- 3.91m2HH- 4H- 44.23d \(J =\) \(12.0\mathrm{Hz}\) 1H;OCHPh4.29d \(J = 7.4\mathrm{Hz}\) 1HH- 14.52d \(J = 12.0\mathrm{Hz}\) 1H;OCHPh4.35d \(J = 12.0\mathrm{Hz}\) 1H;OCHPh4.52d \(J = 3.0\mathrm{Hz}\) 1H;OCHPh4.54d \(J = 11.5\mathrm{Hz}\) 1H;OCHPh4.55d \(J = 3.4\mathrm{Hz}\) 1H; H- 14.63d \(J = 12.0\mathrm{Hz}\) 1H;OCHPh4.66- 4.73m3H \(3\times \mathrm{OC}H\mathrm{Ph}\) 4.75d \(J = 11.5\mathrm{Hz}\) 1H;OCHPh4.80d \(J = 11.5\mathrm{Hz}\) 1H;OCHPh4.81d \(J = 11.3\mathrm{Hz}\) 1H;OCHPh4.96d \(J = 11.5\mathrm{Hz}\) 1H;OCHPh 5.03d \(J = 10.3\mathrm{Hz}\) 1H;OCHPh7.17- 7.37 ppm (m35H;aromatic).<|md_end|>
<|box_start|>075 828 484 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>25: The glycosidation was performed according to the typical procedure \((1\mathrm{mL}\) dioxane \(/\mathrm{Et}_2\mathrm{O}\) 1:1, \(0^\circ \mathrm{C}\) 5 min) employing galactosyl diphenyl phosphate 17 \((77.3\mathrm{mg},0.10\mathrm{mmol})\) , alcohol 19 \((51.1\mathrm{mg},0.11\mathrm{mmol})\) \(\mathrm{HCIO_4}\) \((0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) and pulverized \(5 - \mathrm{\AA}\) M.S.<|md_end|>
<|box_start|>514 081 922 610<|box_end|><|ref_start|>text<|ref_end|><|md_start|>\((50\mathrm{mg})\) .An anomeric mixture of methyl 2,3,6- tri- \(o\) - benzyl- 4- O- (2,3,4,6- tetra- \(o\) - benzyl- D- galactopyranosyl)- \(\mathbb{C}\) - D- galactopyranoside (25; \(80.8\mathrm{mg}\) \(82\%\) \(\alpha /\beta = 87:13\) was obtained as a colorless oil from the crude product \((101.6\mathrm{mg})\) after column chromatography (silica gel \(10\mathrm{g}\) hexane/AcOEt 5:1). The anomeric \(\alpha /\beta\) ratio of disaccharide 25 was determined by HPLC analysis [eluent, hexane/AcOEt 5:1; flow rate, \(1.5\mathrm{mL}\mathrm{min}^{- 1}\) ;detection, \(254~\mathrm{mm}\) . \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 17.6\mathrm{min}\) \(t_\mathrm{R}\) \(\beta\) anomer) \(= 19.6\mathrm{min}\) . The \(\mathbb{C}\) and \(\beta\) - glycosides were separated by preparative thin layer chromatography (hexane \(/\mathrm{CH}_2\mathrm{Cl}_2/\) acetone 20:20:1). Data for \(\alpha\) anomer 25a: \(R_{\mathrm{f}} =\) 0.53 (hexane/AcOEt 2:1), 0.38 (hexane/ \(\mathrm{CHCl}_2/\) acetone 20:20:1) \([\alpha ]_{\mathrm{D}}^{22} =\) \(+38.8\) \(c = 1.00\) in \(\mathrm{CHCl}_2\) IR (film) \(\bar{\nu} = 3062\) 3030,2925,1724,1604, 1496, 1454, 1360, 1207, 1100, \(1050~\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_3\) \(\delta =\) 3.21 (dd, \(J = 5.2\) \(8.6\mathrm{Hz}\) 1H- 6a3.36s3H; \(\mathrm{OCH}_3\) 3.46 (dd \(J = 6.3\) \(9.7\mathrm{Hz}\) 1HH- 43.54 (1H- 8.6 Hz1H- 5H \(3.81 - 3.84\) 1dH- 2H- 3.5, H- 5)3.90- 3.93 (a- 3H;R- 2H- 3H;H- 6a4.95 (a- 4.95 (a- 4.92 (a- 4.91) 4.07- 4.13 (m, 2H; H- 2, H- 6), 4.20 (d, \(J = 12.0\mathrm{Hz}\) 1H;OCHPh)4.23 (d, \(J = 12.0\mathrm{Hz}\) 1H;OCHPh)4.40 (dd, \(J = 5.2\) 8.6 Hz1H;H- 6)4.54 (d \(J =\) \(10.9\mathrm{Hz}\) 1H;OCHPh)4.50d \(J = 12.0\mathrm{Hz}\) 1H;OCHPh)4.69- 4.76 (m, 5H; H- 1, 4×OCHPh)4.80d \(J = 12.0\mathrm{Hz}\) 1H;OCHPh)4.84- 4.87 (m, 2H; \(2\times \mathrm{OC}H\mathrm{Ph}\) 4.89 (d, \(J = 10.9\mathrm{Hz}\) 1H;OCHPh)4.98 (d, \(J = 4.0\mathrm{Hz}\) 1HH- 17.16- 7.42 ppm (m35H;aromatic) \(^{13}\mathrm{C}\) NMR \(\mathrm{(100MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 67.8\) 68.169.269.572.272.672.973.173.374.174.6 74.9, 75.0, 76.2, 76.5, 77.2, 78.0, 79.5, 98.8, 100.3, 127.2, 127.31, 127.34, 127.39, 127.44, 127.47, 127.52, 127.55, 127.62, 127.8, 128.0, 128.08, 128.11, 128.2, 128.27, 128.32, 138.1, 138.2, 138.6, 138.8, 139.0 ppm; FAB- LRMS: \(m / z\) 987.4683, found: 987.4692. Data for \(\beta\) anomer 25B: \(R_{\mathrm{f}} = 0.53\) hexane/ AcOEt 2:1), 0.30 (hexane/ \(\mathrm{CHCl}_3/\) acetone 20:20:1); \([\alpha ]_{\mathrm{D}}^{22} = +19.4\) \(c = 0.40\) in \(\mathrm{CHCl}_2\) IR (film) \(\bar{\nu} = 3062\) 3030,2919,2868,1725,1604,1496,1454, 1360, 1099, \(1050~\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR (500 MHz, \(\mathrm{CDCl}_3\) \(\delta = 3.37\) s3H; \(\mathrm{OCH}_3\) 3.40- 3.43 (m2H;H- 6ab)3.46dd \(J = 2.9\) \(9.7\mathrm{Hz}\) 1HH- 3) 3.52 (t, \(J = 9.2\mathrm{Hz}\) 1H;H- 5)3.64 (dd \(J = 6.3\) \(10.3\mathrm{Hz}\) 1H;H- 6a3.69 (dd, \(J = 4.6\) \(10.3\mathrm{Hz}\) 1H;H- 6b)3.76 (dd, \(J = 7.4\) \(9.7\mathrm{Hz}\) 1H;H- 23.85 (d, \(J = 2.9\mathrm{Hz}\) 1H;H- 4)3.87- 3.93 (m3H;H- 2H- 3H5.4.27 (m1H H- 4)4.32- 4.35 (m3H \(3\times \mathrm{OC}H\mathrm{Ph}\) 4.48 (d \(J = 12.0\mathrm{Hz}\) 1H;OCHPh) 4.55- 4.59 (m3H \(3\times \mathrm{OC}H\mathrm{Ph}\) 4.65 (d \(J = 3.4\mathrm{Hz}\) 1HH- 14.68- 4.70 (m2H2×OCHPh4.76d \(J = 11.3\mathrm{Hz}\) 1H;OCHPh4.74 (d \(J =\) \(12.0\mathrm{Hz}\) 1H;OCHPh)4.79d \(J = 12.0\mathrm{Hz}\) 1H;OCHPh)4.90 (d \(J =\) \(7.4\mathrm{Hz}\) 1H;H- 14.97 (d \(J = 11.5\mathrm{Hz}\) 1H;OCHPh)5.05 (d \(J = 11.5\mathrm{Hz}\) 1H;OCHPh)7.12- 7.38 ppm (m35H;aromatic) \(^{13}\mathrm{C}\) NMR \(\mathrm{(100MHz}\) \(\mathrm{CDCl}_3\) \(\delta = 68.6\) 69.670.172.173.073.373.473.774.074.4974.53 77.2,78.779.881.898.710.8127.1127.28127.31127.34127.36 127.40127.44127.5127.7127.8128.07128.14128.2128.3128.4 137.9, 138.56, 138.58, 138.7, 138.9, 139.0, 139.3 ppm; FAB- LRMS: \(m / z\) 988 \([M + H]^{+}\) FAB- HRMs: \(m / z\) calcd for \(\mathrm{C_{62}H_{67}O_{11}}\) \([M + H]^{+}\) :987.4683, found: 987.4675. <|md_end|>
<|box_start|>514 611 922 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>26: The glycosidation was performed according to the typical procedure \((1\mathrm{mL}\) dioxane/EtO 1:1, \(0^\circ \mathrm{C}\) 5 min) employing galactosyl diphenyl phosphate 17 \((77.3\mathrm{mg},0.10\mathrm{mmol})\) , alcohol 20 \((24.0\mathrm{mg},0.11\mathrm{mmol})\) \(\mathrm{HCIO_4}\) \((0.1\mathrm{M}\) in dioxane, \(0.05\mathrm{mL}\) \(0.005\mathrm{mmol}\) and pulverized \(5 - \mathrm{\AA}\) M.S. \((50\mathrm{mg})\) .An anomeric mixture of methyl \(2,3,0\) - isopropylidene- 4- O- (2,3,4,6- tetra- O- benzyl- D- galactopyranosyl)- \(\mathbb{C}\) - L- rhamnopyranoside[58] (26: \(67.1\mathrm{mg}\) \(91.6\%\) \(\alpha /\beta = 87:13\) was obtained as a colorless oil from the crude product \((169.2\mathrm{mg})\) after column chromatography (silica gel \(12\mathrm{g}\) hexane/ AcOEt 5:1). The anomeric \(\alpha /\beta\) ratio of disaccharide 26 was determined by HPLC analysis [eluent, hexane/THF 6:1; flow rate, \(0.5\mathrm{mL}\mathrm{min}^{- 1}\) ;detection, \(254~\mathrm{mm}\) . \(t_\mathrm{R}\) \(\alpha\) anomer) \(= 19.5\mathrm{min}\) \(t_\mathrm{R}\) \(\beta\) anomer) \(= 20.7\mathrm{min}\) . The \(\alpha\) and \(\beta\) - glycosides were separated by flash column chromatography with \(\mathrm{CH}_2\mathrm{Cl}_2/\) AcOEt (50:1). Data for \(\alpha\) anomer 26a: \(R_{\mathrm{f}} = 0.46\) (hexane/AcOEt 2:1), \(0.30\) \(\mathrm{CH}_2\mathrm{Cl}_2/\) AcOEt 30:1); \([\alpha ]_{\mathrm{D}}^{31} = +33.3\) \(c = 1.06\) in \(\mathrm{CHCl}_2\) IR (film): \(\bar{\nu} = 3064\) 3030,296,2934149714541382137012431220, 1140, 1094, 1049, 1025, 801, \(752~\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{(500~MHz}\) \(\mathrm{CDCl}_3\) \(\delta =\) 1.24 (s, 3H; \(\mathrm{CC}H_3\) 1.29 (d, \(J = 6.9\mathrm{Hz}\) 3H; H- 6)1.36 (s, 3H; \(\mathrm{CC}H_3\) 3.31 (dd, \(J = 7.4\) \(10.3\mathrm{Hz}\) 1H; H- 4)3.32 (s, 3H; \(\mathrm{OC}H_3\) 3.49 (dd, \(J = 4.6\) \(8.0\mathrm{Hz}\) 1H;H- 5)3.65 (dd \(J = 8.0\) \(9.2\mathrm{Hz}\) 1H;H- 6a)3.73 (dd \(J = 6.9\) \(10.3\mathrm{Hz}\) 1H;H- 5)3.96 (dd \(J = 2.9\) \(10.3\mathrm{Hz}\) 1H;H- 3)4.05- 4.08 (m, 2H; H- 2, H- 2)4.13 (m, 2H; H- 3, H- 4)4.24 (dd, \(J = 4.6\) \(9.2\mathrm{Hz}\) 1H;H6b)4.39 (d \(J = 12.0\mathrm{Hz}\) 1H;OCHPh)4.48 (d \(J = 11.5\mathrm{Hz}\) 1H;OCHPh)4.58 (d \(J = 10.9\mathrm{Hz}\) 1H;OCHPh)4.72 (m, 3H \(3\times \mathrm{OC}H\mathrm{Ph}\)<|md_end|>
--------------------------------------------------
<|box_start|>076 081 484 229<|box_end|><|ref_start|>text<|ref_end|><|md_start|>4.82 (s, 1H; H- 1), 4.84 (d, \(J = 12.0 \mathrm{Hz}\), 1H; OCHPh), 4.94- 4.96 (m, 2H; H- 1', OCHPh), 7.24- 7.38 ppm (m, 20H; aromatic). Data for \(\beta\) anomer \(26\beta\): \(R_{\mathrm{I}} = 0.50\) (hexane/AcOEt 2:1), 0.44 \((\mathrm{CH}_2\mathrm{Cl}_2 / \mathrm{AcOEt} \mathrm{30:1})\): \([\alpha ]_{\mathrm{D}}^{22} = - 13.1\) (\(c = 1.08\) in \(\mathrm{CHCl}_3\)) IR (film): \(\bar{\nu} = 30.65\), 3030, 2983, 2933, 2871, 1496, 1454, 1382, 1369, 1242, 1220, 1138, 1092, 1065, 1022, 861, \(734 \mathrm{cm}^{- 1}\); \({}^{1}\mathrm{H}\) NMR \((500 \mathrm{MHz}\), \(\mathrm{CDCl}_3\)): \(\delta = 1.24 - 1.37\) (m, 6H; \(\mathrm{CC}_2\mathrm{H}_5\), H- 6), 1.44 (s, 3H; \(\mathrm{CC}_2\mathrm{H}_5\)), 3.37 (s, 3H; \(\mathrm{CC}_2\mathrm{H}_5\)), 3.51- 3.55 (m, 3H; H- 3, H- 3', H- 6a), 3.59- 3.63 (m, 3H; H- 4, H- 5, H- 4'), 3.73 (dd, \(J = 7.4\), \(9.7 \mathrm{Hz}\), 1H; H- 2), 3.88 (m, 1H; H- 5'), 4.07 (d, \(J = 5.2 \mathrm{Hz}\), 1H; H- 1'), 4.21 (m, 1H; H- 2'), 4.38- 4.50 (m, 2H; H- 6b, OCHPh), 4.61 (d, \(J = 1.0\) Hz, 1H; OCHPh), 4.68- 4.76 (m, 3H; \(3\times \mathrm{OCHPh}\)), 4.81- 4.84 (m, 2H; H- 1, OCHPh), 4.91 (d, \(J = 11.5 \mathrm{Hz}\), 1H; OCHPh), 4.94 (d, \(J = 11.2 \mathrm{Hz}\), 1H; OCHPh), 7.26- 7.40 ppm (m, 20H; aromatic).<|md_end|>
<|box_start|>076 230 484 667<|box_end|><|ref_start|>text<|ref_end|><|md_start|>27: The glycosidation was performed according to the typical procedure \((0.5 \mathrm{mL}\) dioxane \(\mathrm{Et}_2\mathrm{O}\) 1:1, \(25^{\circ} \mathrm{C}\), 2 h) employing 5,4,6- tri- O- acetyl- 2- azido- 2- deoxy- D- galactopyranosyl diphenyl phosphate (18; \(56.3 \mathrm{mg}\), \(0.10 \mathrm{mmol}\)), alcohol 21 \((45.9 \mathrm{mg}\), \(0.11 \mathrm{mmol}\)), \(\mathrm{HClO}_4\) \((0.1 \mathrm{M}\) in dioxane, \(0.2 \mathrm{mL}\), \(0.02 \mathrm{mmol}\)), and pulverized \(5 - \mathrm{\AA}\) M.S. \((50 \mathrm{mg})\). An anomeric mixture of \(N\cdot\) (9- fluorenylmethoxycarbonyl)- O- 3,4,6- tri- O- acetyl- 2- azido- 2- deoxy- D- galactopyranosyl)- L- serine benzyl ester[59] (27; \(60.1 \mathrm{mg}\), \(82\%\), \(\alpha /\beta = 91.9\)) was obtained as a colorless oil from the crude product \((86.3 \mathrm{mg})\) after column chromatography (silica gel \(10 \mathrm{g}\), \(\mathrm{CH}_2\mathrm{Cl}_2/\) acetone 20:1). The anomeric \(\alpha /\beta\) ratio of glycoside 27 was determined by HPLC analysis [eluent, hexane/THF 6:1; flow rate, \(1.5 \mathrm{mL} \mathrm{min}^{- 1}\); detection, \(254 \mathrm{nm}\); \(t_{\mathrm{R}}\) (\(\alpha\) anomer) \(= 39.8 \mathrm{min}\), \(t_{\mathrm{R}}\) (\(\beta\) anomer) \(= 76.8 \mathrm{min}\)). The \(\alpha\) and \(\beta\) glycosides were separated by preparomer thin layer chromatography (toluene/AcOEt 3:1). Data for \(\alpha\) and \(27\alpha\): \(R_{\mathrm{I}} = 0.44\) \((\mathrm{CH}_2\mathrm{Cl}_2/\) acetone 20:1), 0.46 (toluene/AcOEt 3:1); \([\alpha ]_{\mathrm{D}}^{22} = +82.8\) (\(c = 1.50\) in \(\mathrm{CHCl}_3\)) [lit.: \([\alpha ]_{\mathrm{D}}^{21} = +84\) (\(c = 1.0\) in \(\mathrm{CHCl}_3\))] [59] IR (film): \(\bar{\nu} = 33.60\), 3032, 2951, 2112, 1751, 1521, 1450, 1371, \(1230 \mathrm{cm}^{- 1}\); \({}^{1}\mathrm{H}\) NMR \((500 \mathrm{MHz}\), \(\mathrm{CDCl}_3\)): \(\delta = 1.94\) (s, 3H; \(\mathrm{CH}_2\mathrm{CO}\)), 2.05 (s, 3H; \(\mathrm{CH}_3\mathrm{CO}\)), 2.13 (s, 3H; \(\mathrm{CH}_2\mathrm{CO}\)), 3.58 (dd, \(J = 3.2\), \(11.1 \mathrm{Hz}\), 1H; H- 2), 3.96- 4.08 (m, 4H; H- 5, H- 4,6- dim, OCH), 4.14 (dd, \(J = 2.8\), \(11.2 \mathrm{Hz}\), 1H; OCH), 4.22 (br t, \(J = 7.0 \mathrm{Hz}\), 1H; Fmoc- CH), 4.40 (d, \(J = 7.0 \mathrm{Hz}\), 2H; Fmoc- \(\mathrm{CH}_2\)), 4.61 (m, 1H; NCH), 4.86 (d, \(J = 3.2 \mathrm{Hz}\), 1H; H- 1), 5.21 (d, \(J = 12.1 \mathrm{Hz}\), 1H; \(\mathrm{CO}_2\mathrm{CHPh}\)), 5.24 (d, \(J = 12.1 \mathrm{Hz}\), 1H; \(\mathrm{CO}_2\mathrm{CHPh}\)), 5.27 (dd, \(J = 2.6\), \(11.1 \mathrm{Hz}\), 1H; H- 3), 5.38 (br s, 1H; H- 4), 5.93 (d, \(J = 8.0 \mathrm{Hz}\), 1H; NH), 7.28- 7.40 (m, 9H); aromatic), 7.61 (m, 2H; aromatic), 7.74 ppm (d, \(J = 7.5 \mathrm{Hz}\), 2H; aromatic). Data for \(\beta\) anomer 27b: \(R_{\mathrm{I}} = 0.42\) \((\mathrm{CH}_2\mathrm{Cl}_2/\) acetone 20:1), 0.42 (toluene/AcOEt 3:1); \([\alpha ]_{\mathrm{D}}^{22} = -9.3\) (\(c = 0.40\) in \(\mathrm{CHCl}_3\)) [lit.: \([\alpha ]_{\mathrm{D}}^{22} = -7.1\), (\(c = 1\) in \(\mathrm{CHCl}_3\))] [59] IR (film): \(\bar{\nu} = 3360\), 2951, 2110, 1751, 1521, 1450, 1371, \(1228 \mathrm{cm}^{- 1}\); \({}^{1}\mathrm{H}\) NMR \((500 \mathrm{MHz}\), \(\mathrm{CDCl}_3\)): \(\delta = 2.02\) (s, 3H; \(\mathrm{CH}_2\mathrm{CO}\)), 2.06 (s, 3H; \(\mathrm{CH}_2\mathrm{CO}\)), 2.16 (s, 3H; \(\mathrm{CH}_2\mathrm{CO}\)), 3.66 (dd, \(J = 8.2\), \(10.8 \mathrm{Hz}\), 1H; H- 2), 3.76 (dd, \(J = 6.5\), \(7.0 \mathrm{Hz}\), 1H; H- 5), 3.93 (dd, \(J = 2.9\), \(10.1 \mathrm{Hz}\), 1H; OCH), 4.09 (dd, \(J = 6.5\), \(11.1 \mathrm{Hz}\), 1H; H- 6a), 4.12 (dd, \(J = 7.0\), \(11.1 \mathrm{Hz}\), 1H; H- 6b), 4.23 (dd, \(J = 6.7\), \(7.4 \mathrm{Hz}\), 1H; Fmoc- CH), 4.32 (d, \(J = 8.2 \mathrm{Hz}\), 1H; H- 1), 4.37 (dd, \(J = 7.4\), \(10.5 \mathrm{Hz}\), 1H; Fmoc- CH), 4.41- 4.44 (m, 1H; OCH, Fmoc- CH), 4.63 (m, 1H; NCH), 4.76 (dd, \(J = 3.2\), \(10.8 \mathrm{Hz}\), 1H; H- 3), 5.23 (d, \(J = 12.3 \mathrm{Hz}\), 1H; \(\mathrm{CO}_2\mathrm{CHPh}\)), 5.27 (d, \(J = 12.3 \mathrm{Hz}\), 1H; \(\mathrm{CO}_2\mathrm{CHPh}\)), 5.32 (d, \(J = 3.2 \mathrm{Hz}\), 1H; H- 4), 5.84 (d, \(J = 8.2 \mathrm{Hz}\), 1H; NH), 7.29- 7.41 (m, 9H; aromatic), 7.61 (m, 2H; aromatic), 7.77 ppm (d, \(J = 7.6 \mathrm{Hz}\), 2H; aromatic).<|md_end|>
<|box_start|>076 669 484 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>28: The glycosidation was performed according to the typical procedure \((0.5 \mathrm{mL}\) dioxane \(\mathrm{Et}_2\mathrm{O}\) 1:1, \(25^{\circ} \mathrm{C}\), 6 h) employing chlorphenyl phosphate 18 \((56.3 \mathrm{mg}\), \(0.10 \mathrm{mmol}\), alcohol 22 \((47.5 \mathrm{mg}\), \(0.11 \mathrm{mmol}\), \(\mathrm{HClO}_4\) \((0.1 \mathrm{M}\) in dioxane, \(0.2 \mathrm{mL}\), \(0.02 \mathrm{mmol}\)), and pulverized \(5 - \mathrm{\AA}\) M.S. \((50 \mathrm{mg})\). An anomeric mixture of \(N\cdot\) (9- fluorenylmethoxycarbonyl)- \(O\)- (3,4,6- tri- \(O\)- acetyl- 2- azido- 2- deoxy- D- galactopyranosyl)- L- threonine benzyl ester[59a,b] (28; \(58.2 \mathrm{mg}\), \(78\%\), \(\alpha /\beta = 92.8\)) was obtained as a colorless oil from the crude product \((105.6 \mathrm{mg})\) after column chromatography (silica gel \(10 \mathrm{g}\), \(\mathrm{CH}_2\mathrm{Cl}_2/\) acetone 20:1). The anomeric \(\alpha /\beta\) ratio of glycoside 28 was determined by HPLC analysis [eluent, hexane/THF 6:1; flow rate, \(1.5 \mathrm{mL} \mathrm{min}^{- 1}\); detection, \(254 \mathrm{nm}\); \(t_{\mathrm{R}}\) (\(\alpha\) anomer) \(= 39.7 \mathrm{min}\), \(t_{\mathrm{R}}\) (\(\beta\) anomer) \(= 51.2 \mathrm{min}\)]. The \(\alpha\) and \(\beta\)- glycosides were separated by preparative thin layer chromatography (toluene/AcOEt 3:1). Data for \(\alpha\) anomer 28a: \(R_{\mathrm{I}} = 0.44\) \((\mathrm{CH}_2\mathrm{Cl}_2/\) acetone 20:1), 0.46 (toluene/AcOEt 3:1); \([\alpha ]_{\mathrm{D}}^{20} = +65.1\) (\(c = 1.00\) in \(\mathrm{CHCl}_3\)) [lit.: \([\alpha ]_{\mathrm{D}}^{22} = +63\) (\(c = 1\) in \(\mathrm{CHCl}_3\))] [59] IR (film): \(\bar{\nu} = 3356\), 3032, 2951, 2112, 1751, 1518, 1450, 1371, \(1230 \mathrm{cm}^{- 1}\); \({}^{1}\mathrm{H}\) NMR \((500 \mathrm{MHz}\), \(\mathrm{CDCl}_3\)): \(\delta = 1.33\) (d, \(J = 6.4 \mathrm{Hz}\), 3H; \(\mathrm{OCH}_2\mathrm{H}_5\)), 2.00 (s, 3H; \(\mathrm{CH}_3\mathrm{CO}\)), 2.05 (s, 3H; \(\mathrm{CH}_3\mathrm{CO}\)), 2.12 (s, 3H; \(\mathrm{CH}_3\mathrm{CO}\)), 3.58 (dd, \(J = 3.7\),<|md_end|>
<|box_start|>515 082 922 343<|box_end|><|ref_start|>text<|ref_end|><|md_start|>\(11.2 \mathrm{Hz}\), 1H; H- 2), 4.06 (d, \(J = 6.5 \mathrm{Hz}\), 2H; H- 6ab), 4.22 (br t, \(J = 6.5 \mathrm{Hz}\), 1H; H- 5), 4.23 (t, \(J = 7.5 \mathrm{Hz}\), 1H; Fmoc- CH), 4.34 (dd, \(J = 7.5\), \(10.5 \mathrm{Hz}\), 1H; Fmoc- CH), 4.42 (dd, \(J = 7.5\), \(10.5 \mathrm{Hz}\), 1H; Fmoc- CH), 4.45 (dq, \(J = 1.5\), \(6.4 \mathrm{Hz}\), 1H; OCHCH}_3, 4.49 (dd, \(J = 1.5\), \(9.5 \mathrm{Hz}\), 1H; NCH), 4.89 (d, \(J = 3.7 \mathrm{Hz}\), 1H; H- 1), 5.18 (d, \(J = 12.2 \mathrm{Hz}\), 1H; \(\mathrm{CO}_2\mathrm{CHPh}\)), 5.25 (d, \(J = 12.2 \mathrm{Hz}\), 1H; \(\mathrm{CO}_2\mathrm{CHPh}\)), 5.28 (dd, \(J = 3.1\), \(11.2 \mathrm{Hz}\), 1H; H- 3), 5.44 (d, \(J = 3.1 \mathrm{Hz}\), 1H; H- 4), 5.74 (d, \(J = 9.5 \mathrm{Hz}\), 1H; NH), 7.27- 7.39 (m, 9H; aromatic), 7.61 (d, \(J = 7.4 \mathrm{Hz}\), 2H; aromatic), 7.74 ppm (d, \(J = 7.6 \mathrm{Hz}\), 2H; aromatic). Data for \(\beta\) anomer 28b: \(R_{\mathrm{I}} = 0.43\) \((\mathrm{CH}_2\mathrm{Cl}_2/\) acetone 20:1), 0.43 (toluene/AcOEt 3:1); \([\alpha ]_{\mathrm{D}}^{22} = -17.0\) (\(c = 0.68\) in \(\mathrm{CHCl}_3\)) [lit.: \([\alpha ]_{\mathrm{D}}^{22} = -14\) (\(c = 1\) in \(\mathrm{CHCl}_3\))] [59a] IR (film): \(\bar{\nu} = 3358\), 3032, 2951, 2110, 1751, 1518, 1450, 1373, 1230, 1035 cm\(^{- 1}\); \({}^{1}\mathrm{H}\) NMR \((500 \mathrm{MHz}\), \(\mathrm{CDCl}_3\)): \(\delta = 1.35\) (d, \(J = 6.3 \mathrm{Hz}\), 3H; \(\mathrm{OCHCH}_3\)), 2.02 (s, 3H; \(\mathrm{CH}_2\mathrm{CO}\)), 2.05 (s, 3H; \(\mathrm{CH}_3\mathrm{CO}\)), 2.13 (s, 3H; \(\mathrm{CH}_2\mathrm{CO}\)), 3.59 (d, \(J = 3.3\), \(10.9 \mathrm{Hz}\), 1H; H- 2), 4.01 (d, \(J = 6.2\), \(11.0 \mathrm{Hz}\), 1H; H- 5a), 4.09 (dd, \(J = 7.5\), \(11.0 \mathrm{Hz}\), 1H; H- 6b), 4.25 (d, \(J = 7.3 \mathrm{Hz}\), 1H; Fmoc- CH), 4.29 (d, \(J = 8.0 \mathrm{Hz}\), 1H; H- 1), 4.38 (dd, \(J = 7.3\), \(10.5 \mathrm{Hz}\), 1H; Fmoc- CH), 4.41 (dd, \(J = 7.3\), \(10.5 \mathrm{Hz}\), 1H; Fmoc- CH), 4.51 (dd, \(J = 1.2\), \(9.5 \mathrm{Hz}\), 1H; NCH), 4.59 (dq, \(J = 1.2\), \(6.3 \mathrm{Hz}\), 1H; \(\mathrm{OCHCH}_3\)), 4.67 (dd, \(J = 3.2\), \(10.9 \mathrm{Hz}\), 1H; H- 3), 5.19 (d, \(J = 12.3 \mathrm{Hz}\), 1H; \(\mathrm{OCHPh}\)), 5.23 (d, \(J = 12.3 \mathrm{Hz}\), 1H; \(\mathrm{OCHPh}\)), 5.26 (d, \(J = 3.2 \mathrm{Hz}\), 1H; H- 4), 5.66 (d, \(J = 9.5 \mathrm{Hz}\), 1H; NH), 7.28- 7.41 (m, 9H; aromatic), 7.61 (m, 2H; aromatic), 7.76 ppm (d, \(J = 7.7 \mathrm{Hz}\), 2H; aromatic).<|md_end|>
<|box_start|>515 352 662 363<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Synthesis of KRN7000 (29)<|md_end|>
<|box_start|>514 370 922 803<|box_end|><|ref_start|>text<|ref_end|><|md_start|>31: The glycosidation was performed according to the typical procedure \((1 \mathrm{mL}\) dioxane, \(25^{\circ} \mathrm{C}\), 5 min) employing diphenyl phosphate 17 \((16.2 \mathrm{mg}\), \(0.022 \mathrm{mmol}\)), ceramide 30 \((17.5 \mathrm{mg}\), \(0.02 \mathrm{mmol}\)), \(\mathrm{HClO}_4\) \((0.1 \mathrm{M}\) in dioxane, \(0.1 \mathrm{mL}\), \(0.01 \mathrm{mmol}\)), and pulverized \(5 - \mathrm{\AA}\) M.S. \((20 \mathrm{mg})\). An anomeric mixture of \((2S,3S,4R)\)- 3,4- di- O- benzyl- 1- O- (2,3,4,6- tetra- O- benzyl- D- galactopyranosyl)- 2- N- hexanoylamino- 1,3,4- octadecenetriol[42b] (31; \(25.0 \mathrm{mg}\), \(92\%\), \(\alpha /\beta = 92.8\)) was obtained as a white solid from the crude product \((33.1 \mathrm{mg})\) after column chromatography (silica gel \(6 \mathrm{g}\), hexane/AcOEt 6:1). The anomeric \(\alpha /\beta\) ratio of galactoside 31 was determined by HPLC analysis [eluent, hexane/AcOEt 5:1; flow rate, \(1.5 \mathrm{mL} \mathrm{min}^{- 1}\); detection, \(254 \mathrm{nm}\); \(t_{\mathrm{R}}\) (\(\alpha\) anomer) \(= 8.3 \mathrm{min}\), \(t_{\mathrm{R}}\) (\(\beta\) anomer) \(= 19.8 \mathrm{min}\)). The \(\alpha\) and \(\beta\)- glycosides were separated by flash flash chromatography with hexane/AcOEt 7:1). Data for ananomer 31a: \(R_{\mathrm{I}} = 0.50\) (hexane/AcOEt 4:1); m.p. \(75.5 - 76.0^{\circ} \mathrm{C}\) [lit.: m.p. \(774 - 75^{\circ} \mathrm{C}\))] \([\alpha ]_{\mathrm{D}}^{22} = +19.1\) (\(c = 1.00\) in \(\mathrm{CHCl}_3\)) [lit.: \([\alpha ]_{\mathrm{D}}^{22} = +18.8\) (\(c = 0.00\) in \(\mathrm{CHCl}_3\))] [42b] IR (KBr): \(\bar{\nu} = 3330\), 2920, 2850, 1647, 1532, 1496, 1469, 1454, 1348, 1117, 1060, 736, 695 cm\(^{- 1}\); \({}^{1}\mathrm{H}\) NMR \((400 \mathrm{MHz}\), \(\mathrm{CDCl}_3\)): \(\delta = 0.08\) (t, \(J = 6.9 \mathrm{Hz}\), 6H; \(2\times \mathrm{CH}_5\)), \(122.170 \mathrm{m}\), \(72 \mathrm{m}\); \(36\times \mathrm{CH}_2\mathrm{Cl}_2\), \(1.87 - 2.00 \mathrm{m}\), \(2.33 \mathrm{m}\), \(3.63\) (dd, \(J = 6.3\) (dd, \(J = 6.3 \mathrm{Hz}\), 1H; H- 6a), 3.47- 3.50 (m, 2H; H- 4, H- 6b), 3.72 (dd, \(J = 3.8\), \(10.9 \mathrm{Hz}\), 1H; H- 1a), 3.85- 3.93 (m, 4H; H- 3, H- 3', H- 4', H- 5'), 3.99- 4.05 (m, 2H; H- 1b, H- 2'), 4.12- 4.18 (m, 1H; H- 2), 4.35 (d, \(J = 11.8 \mathrm{Hz}\), 1H; OCHPh), 4.41 (d, \(J = 11.7 \mathrm{Hz}\), 1H; OCHPh), 4.47 (d, \(J = 11.8 \mathrm{Hz}\), 1H; OCHPh), 4.51 (d, \(J = 11.5 \mathrm{Hz}\), 1H; OCHPh), 4.56 (d, \(J = 11.5 \mathrm{Hz}\), 1H; OCHPh), 4.58 (d, \(J = 11.7 \mathrm{Hz}\), 1H; OCHPh), 4.63 (d, \(J = 11.7 \mathrm{Hz}\), 1H; OCHPh), 4.71- 4.80 (m, 4H; \(4\times \mathrm{OCHPh}\)), 4.84 (d, \(J = 3.6 \mathrm{Hz}\), 1H; H- 1'), 4.91 (d, \(J = 11.5 \mathrm{Hz}\), 1H; OCHPh), 6.18 (d, \(J = 8.3 \mathrm{Hz}\), 1H; NHCO), 7.21- 7.37 ppm (m, 30H; aromatic). Data for \(\beta\) anomer 31b: \(R_{\mathrm{I}} = 0.37\) (hexane/AcOEt 4:1); m.p. \(53.5 - 54.5^{\circ} \mathrm{C}\) [lit.: m.p. \(54 - 56^{\circ} \mathrm{C}\))] [42b] \([\alpha ]_{\mathrm{D}}^{21} = - 1.7\) (\(c = 0.74\) in \(\mathrm{CHCl}_3\)) [lit.: \([\alpha ]_{\mathrm{D}}^{22} = - 0.4\) (\(c = 1.0\) in \(\mathrm{CHCl}_3\))] [42b] IR (KBr): \(\bar{\nu} = 3433\), 3325, 3031, 2919, 1646, 1536, 1468, 1454, 1111, \(1072\), 733, 696 cm\(^{- 1}\); \({}^{1}\mathrm{H}\) NMR \((400 \mathrm{MHz}\), \(\mathrm{CDCl}_3\)): \(\delta = 0.88\) (t, \(J = 6.9 \mathrm{Hz}\), 6H; \(2\times \mathrm{CH}_5\)), \(12.2 - 1.70\) (m, 72H; \(36\times \mathrm{CH}_2\)), \(1.87 - 2.00\) (m, 2H; H- 2ab), 3.47- 3.43 (m, 1H; H- 4), 3.51- 3.53 (m, 3H; H- 3', H- 5', H- 6'a), 3.58- 3.61 (m, 1H; H- 6'b), 3.65 (dd, \(J = 3.2\), \(10.1 \mathrm{Hz}\), 1H; H- 1a), 3.78- 3.84 (m, 2H; H- 3, H- 2'), 3.94 (d, \(J = 2.4 \mathrm{Hz}\), 1H; H- 4'), 4.14- 4.26 (m, 2H; H- 1b, H- 2), 4.30 (d, \(J = 9.7 \mathrm{Hz}\), 1H; H- 1'), 4.36- 4.43 (m, 3H; \(3\times \mathrm{OCHPh}\)), 4.53- 4.58 (m, 5H; \(5\times \mathrm{OCHPh}\)), 4.58 (d, \(J = 11.5 \mathrm{Hz}\), 1H; OCHPh), 5.89 (d, \(J = 8.3 \mathrm{Hz}\), 1H; NHCO), 7.21- 7.33 ppm (m, 30H; aromatic).<|md_end|>
<|box_start|>514 805 922 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>29 (KRN7000): \(\mathrm{Pd(OH)}_2\) on carbon \((20\% ,10\mathrm{mg})\) was added to a stirred solution of galactosylceramide 31a \((28.0\mathrm{mg}\) \(0.02\mathrm{mmol}\) in \(\mathrm{CH}_2\mathrm{Cl}_2/\) EtOH \((13,3\mathrm{mL})\) , and the mixture was vigorously stirred under 1 atm of hydrogen for \(12\mathrm{h}\) . The catalyst was filtered through a celite pad, and the filtrate was evaporation in vacuo. Purification by recrystallization (EtOH/ \(\mathrm{H}_2\mathrm{O}\) 10:1) afforded \((2S,3S,4R)\) - 1- O- (a- D- galactopyranosyl)- 2- N- hexanoyl<|md_end|>
--------------------------------------------------
<|box_start|>076 082 484 252<|box_end|><|ref_start|>text<|ref_end|><|md_start|>amino- 3,4- octadecenediol[39,42] (KRN7000, 29, \(13.4\mathrm{mg}\) \(73\%\) ) as a white solid: \(R_{\mathrm{c}} = 0.27\) \(\mathrm{CH_3Cl_6 / MeOH}\) 9:1m.p.192- 193C [lit.m.p. \(189.5- \) \(190.5^{\circ}\mathrm{C}]\) \([a_{\mathrm{L}}^{11}]^{\mathrm{T}} = +43.6\) \(c = 1.04\) in pyridine) [lit.: \([a_{\mathrm{D}}^{12}] = +43.6\) \(c = 1.0\) in pyridine) \([^{39\mathrm{a}}]\) \([a_{\mathrm{L}}^{12}] = +42.2\) \(c = 0.54\) in pyridine)] \([^{42\mathrm{d}}]\) IR (KBr) \(\bar{\nu} =\) 3337,2919,2850,1663,1539,1464 \(1077~\mathrm{cm^{- 1}}\) \({}^{1}\mathrm{H}\) NMR \(\mathrm{(400~MHz)}\) \([\mathrm{D}_6]\) pyridine): \(\delta = 0.87\) \(\mathrm{t}\) \(J = 6.7 \mathrm{Hz}\) 6H \(2.5\mathrm{CH}_3\) 1.25- 1.49 \((\mathrm{m},66\mathrm{H}\) \(33\times \mathrm{CH}_2\) 1.66- 1.74 m1HH- 6a1.77- 1.86 m2HH- 31.87- 1.98 m2HH- 5aH- 6b2.26- 2.24 m1HH- 7b2.45t \(J = 7.5 \mathrm{Hz}\) 2H H- 2)4.33- 4.35 m2HH- 3H- 4)4.38- 4.47 m4HH- 1a \(\mathrm{H - 3^{\prime\prime}}\) \(\mathrm{H} - 5^{\prime \prime}\) \(\mathrm{H - 6^{\prime\prime}a)}\) 4.52- 4.55 m1H \(\mathrm{H - 6^{\prime}b)}\) 4.56- 4.57 m1H \(\mathrm{H - 4^{\prime\prime}}\) 4.65- 4.71 m2HH- 1bH- 2)5.29 m1HH- 25.60d \(J = 3.9 \mathrm{Hz}\) 1H \(\mathrm{H - 1^{\prime\prime}}\) \(8.53\mathrm{ppm}\) d \(J = 8.4 \mathrm{Hz}\) 1H \(\mathrm{NHCO})\) \(^{13}\mathrm{CN}\) R \(100\mathrm{MHz}\) \([\mathrm{D}_6]\) pyridine): \(\delta = 14.8\) 23.5,26.9,27.0,30.10,30.13,30.25,30.32,30.37,30.41,30.47, 30.50,30.54,30.7,30.9,32.6,34.8,37.3,51.8,63.0,69.0,70.6,71.3,71.9, 72.8,73.7,77.9,101.8 \((\mathrm{C1})\) 173.2 ppm (NHCO)<|md_end|>
<|box_start|>205 300 357 314<|box_end|><|ref_start|>title<|ref_end|><|md_start|># Acknowledgements<|md_end|>
<|box_start|>076 325 483 416<|box_end|><|ref_start|>text<|ref_end|><|md_start|>This research was supported in part by a Grant- in- Aid for Scientific Research on Priority Areas 18032002 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). We also acknowledge the Japan Society for the Promotion of Science JSPS) for graduate fellowships to R.A.and T.T. We thank Ms. H. Matsumoto,A.Maeda,S.Oka, and M. Kiuchi, and Mr. T. Hirose of the Center for Instrumental Analysis, Hokkaido University, for technical assistance in mass and elemental analyses.<|md_end|>
<|box_start|>082 440 484 873<|box_end|><|ref_start|>text<|ref_end|><|md_start|>[1] For recent reviews, see: a) K. Toshima, K. Tsubota, Chem. Rev. 1993, 93, 1503- 1531; b) G.- J. Boons, Tetrahedron 1996, 52, 1095- 1121; c) Modern Methods in Carbohydrate Synthesis (Eds.: S. H. Khan, R. A. O'Neil), Harwood Academic Publishers, Amsterdam, 1996; d) Carbohydrates in Chemistry and Biology (Eds.: B. Ernst, G. W. Hart, P. Sinay), VCH, Weinheim, 2000, Part I; e) B. G. Davis, J. Chem. Soc. Perkin Trans. 1 2000, 2137- 2140; f) Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance (Ed.: A. V. Demchenko), VCH, Weinheim, 2008. [2] For recent reviews, see: a) A. V. Demchenko, Curr. Org. Chem. 2003, 7, 35- 79; b) A. V. Demchenko, Synlett 2003, 1225- 1240. [3] Very recently, the (1S)- phenyl- 2- (phenylsulfonyl)ethyl group was developed as an O- 2 protecting group with an anchimeric assistance for the exclusive formation of \(\alpha\)- glycosides: J.- H. Kim, H. Yang, J. Park, G.- J. Boons, J. Am. Chem. Soc. 2005, 127, 12090- 12097. [4] Kiso and co- workers reported that the 4,6- O- di- tert- butylsilylene- protected galactosyl and galactosaminyi donors exhibited good to excellent \(\alpha\) selectivities despite the presence of C- 2 functionalities capable of neighboring group participation: a) A. Imamura, H. Ando, S. Korogi, G. Tanabe, O. Muraoka, H. Ishida, M. Kiso, Tetrahedron Lett. 2003, 44, 6725- 6728; b) A. Imamura, A. Kimura, H. Ando, H. Ishida, M. Kiso, Chem. Eur. J. 2006, 12, 8862- 8870. [5] R. U. Lemieux, K. B. Hendriks, R. V. Stock, K. James, J. Am. Chem. Soc. 1975, 97, 4056- 4062. [6] For reviews that include discussions regarding the effect of ethereal solvents, see: a) G. Wulff, G. Röhle, Angew. Chem. 1974, 86, 173- 187; Angew. Chem. Int. Ed. Engl. 1974, 13, 157- 170; b) A. V. Demchenko in Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance (Ed.: A. V. Demchenko), VCH, Weinheim, 2008, pp. 1- 27. [7] For representative examples of the use of ether, which leads to the formation of an \(\alpha\)- glycosidic linkage, see: a) S. Hashimoto, M. Hayashi, R. Noyori, Tetrahedron Lett. 1984, 25, 1379- 1382; b) M. Kreuzer, J. Thiem, Carbohydr. Res. 1986, 149, 347- 361; c) H. Lönn, J. Carbohydr. Chem. 1987, 6, 301- 306; d) Y. Ito, T. Ogawa, Tetrahedron Lett. 1987, 28, 4701- 4704. [8] The first example of the use of glycosyl perchlorates was reported by Igarashi and co- workers. They found that glycosyl perchlorates, <|txt_contd|><|md_end|>
<|box_start|>514 082 923 876<|box_end|><|ref_start|>text<|ref_end|><|md_start|>generated from glycosyl chlorides and \(\mathrm{AgClO_4}\) and characterized on the basis of \({}^{1}\mathrm{H}\) NMR experiments, exhibited good \(\alpha\) selectivities when treated with \(\mathrm{MoOH}\) in \(\mathrm{Et}_2\mathrm{O}\): a) K. Igarashi, T. Honma, J. Irisawa, Carbohydr. Res. 1970, 15, 329- 337; b) K. Igarashi, J. Irisawa, T. Honma, Carbohydr. Res. 1975, 39, 213- 225. [9] a) T. Mukaiyama, Y. Murai, S. Shoda, Chem. Lett. 1981, 431- 432; b) Y. Nakahara, T. Ogawa, Tetrahedron Lett. 1987, 28, 2731- 2734; c) T. Matsumoto, H. Maeta, K. Suzuki, G. Tsuchihashi, Tetrahedron Lett. 1988, 29, 3567- 3570; d) G. H. Veeneman, J. H. van Boom, Tetrahedron Lett. 1990, 31, 277- 278; e) W.- S. Kim, S. Hosono, H. Sasai, M. Shibasaki, Tetrahedron Lett. 1995, 36, 4443- 4446; f) A. Demchenko, T. Stauch, G. J. Boons, Synlett 1997, 818- 820; g) K. Fukase, Y. Nakai, T. Kanoh, S. Kusumoto, Synlett 1998, 84- 86; h) M. Wakao, Y. Nakai, K. Fukase, S. Kusumoto, Chem. Lett. 1999, 27- 28; i) A. V. Demchenko, E. Beaumont, G. J. Boons, Tetrahedron Lett. 1999, 40, 6523- 6526; j) H. Jona, H. Mandai, T. Mukaiyama, Chem. Lett. 2001, 426- 427; k) T. Mukaiyama, M. Suenaga, H. Chiba, H. Jona, Chem. Lett. 2002, 56- 57; l) H. Jona, H. Mandai, W. Chavasiri, K. Takeuchi, T. Mukaiyama, Bull. Chem. Soc. Jpn. 2002, 75, 291- 309; m) J. Matsuo, T. Shirahata, S. Omura, Tetrahedron Lett. 2006, 47, 267- 271. [10] a) T. Ziegler, R. Lau, Tetrahedron Lett. 1995, 36, 1417- 1420; b) S. C. Ennis, A. J. Fairbanks, R. J. Tennant- Eyles, H. S. Yeates, Synlett 1999, 1387- 1390; c) C. M. P. Seward, I. Cumpstey, M. Aloui, S. C. Ennis, A. J. Redgrave, A. J. Fairbanks, Chem. Commun. 2000, 1409- 1410; d) T. Ziegler, G. Lemanski, J. Huttlen, Tetrahedron Lett. 2001, 42, 569- 572; e) M. Müller, R. R. Schmidt, Eur. J. Org. Chem. 2001, 2055- 2066; f) C. C. Ennis, A. J. Fairbanks, C. A. Slinn, R. J. Tennant- Eyles, H. S. Yeates, Tetrahedron 2001, 57, 4221- 4230. [11] For reviews, see: a) K.- H. Jung, M. Müller, R. R. Schmidt, Chem. Rev. 2000, 100, 4423- 4442; b) A. J. Fairbanks, Synlett 2003, 1945- 1958. [12] a) S. Houdier, P. J. A. Vottero, Carbohydr. Res. 1992, 232, 349- 352; b) G.- J. Boons, S. Bowers, D. M. Coe, Tetrahedron Lett. 1997, 38, 3773- 3776; c) H. Tokimoto, Y. Fujimoto, K. Fukase, S. Kusumoto, Tetrahedron: Asymmetry 2005, 16, 441- 447. [13] H. A. Orgueira, A. Bartolozzi, P. Schell, P. H. Seeburger, Angew. Chem. 2002, 114, 2233- 2235; Angew. Chem. Int. Ed. 2002, 41, 2128- 2131. [14] a) R. Eby, C. Schuchch, Carbohydr. Res. 1974, 34, 79- 90; b) Y.- P. Cheng, H.- T. Chen, C.- C. Lin, Tetrahedron Lett. 2002, 43, 7721- 7723; c) N. Ustyuzhanina, B. Komarova, N. Zlotina, V. Krylov, A. Gerbst, Y. Tsvetkov, N. Nifantiev, Synlett 2006, 921- 923; d) A. Ishiwata, S. Ohta, Y. Ito, Carbohydr. Res. 2006, 341, 1557- 1573. [15] For the use of diphenyl phosphate as a leaving group, see: a) S. Hashimoto, T. Honda, S. Ikegami, J. Chem. Soc. Chem. Commun. 1989, 685- 687; b) T. Tsuda, S. Nakamura, S. Hashimoto, Tetrahedron Lett. 2003, 44, 6453- 6457; c) T. Tsuda, S. Nakamura, S. Hashimoto, Tetrahedron 2004, 60, 10711- 10737. [16] For the use of \(P,P\)- isphenyl- \(N\)- (p- toluenesulfonyl)phosphinimidate as a leaving group, see: a) S. Hashimoto, T. Honda, S. Ikegami, Heterocycles 1990, 30, 775- 778; b) S. Hashimoto, T. Honda, S. Ikegami, Chem. Pharm. Bull. 1999, 38, 2323- 2325; c) S. Hashimoto, T. Honda, S. Ikegami, Tetrahedron Lett. 1999, 38, 2323- 2325; d) S. Hashimoto, T. Honda, S. Ikegami, Tetrahedron Lett. 1991, 32, 1653- 1654. [17] For the use of \(N,N,N^{\prime},N^{\prime}\)- tetramethyl- \(N^{\prime}\)- phenylphosphorodiamidimidothioate as a leaving group, see: S. Hashimoto, T. Honda, S. Ikegami, Tetrahedron Lett. 1990, 31, 4769- 4772. [18] For the use of \(N,N,N^{\prime},N^{\prime}\)- tetramethylphosphorodiamidate as a leaving group, see: a) S. Hashimoto, Y. Yanagiya, T. Honda, H. Harada, S. Ikegami, Tetrahedron Lett. 1992, 33, 3523- 3526; b) S. Hashimoto, Y. Yanagiya, T. Honda, S. Ikegami, Chem. Lett. 1992, 1511- 1514; c) T. Iimori, H. Kobayashi, S. Hashimoto, S. Ikegami, Heterocycles 1996, 42, 485- 488. [19] For the use of diethylphosphite as a leaving group, see: a) S. Hashimoto, K. Umeo, A. Sano, N. Watanabe, M. Nakajima, S. Ikegami, Tetrahedron Lett. 1993, 36, 2251- 2254; b) S. Hashimoto, A. Sano, H. Sakamoto, M. Nakajima, Y. Yanagiya, S. Ikegami, Synlett 1995, 1271- 1273; c) S. Hashimoto, A. Sano, K. Umeo, M. Nakajima, S. Ikegami, Chem. Pharm. Bull. 1995, 43, 2267- 2269; d) S. Hashimoto,<|md_end|>
--------------------------------------------------
<|box_start|>074 078 485 876<|box_end|><|ref_start|>text<|ref_end|><|md_start|>J. Inagaki, 
H. Sakamoto, 
A. Sano, 
M. Nakajima, Heterocycles 1997, 46, 215-220; 
e) 
H. Tanaka, 
H. Sakamoto, 
A. Sano, 
S. Nakamura, 
M. Nakajima, 
S. Hashimoto, Chem. Commun. 1999, 1259-1260; 
f) 
J. Inagaki, 
H. Sakamoto, 
M. Nakajima, 
S. Nakamura, 
S. Hashimoto, Synlett 1999, 1274-1276; 
g) 
T. Tsuda, 
S. Sato, 
S. Nakamura, 
S. Hashimoto, Heterocycles 2003, 59, 509-515; 
h) 
H. Arihara, 
S. Nakamura, 
S. Hashimoto, Angew. Chem. 2005, 117, 2285-2289; Angew. Chem. Int. Ed. 2005, 44, 2245-2249; 
i) 
T. Tsuda, 
R. Arihara, 
S. Sato, 
M. Koshiba, 
S. Nakamura, 
S. Hashimoto, Tetrahedron 2005, 61, 10719-10733. [20] For chemoselective glycosidation strategies contextualizing on phosphorus-containing leaving groups, see: a) 
S. Hashimoto, 
H. Sakamoto, 
T. Honda, 
S. Ikegami, Tetrahedron Lett. 1997, 38, 5181-5184; 
b) 
S. Hashimoto, 
H. Sakamoto, 
T. Honda, 
H. Abe, 
S. Nakamura, 
S. Ikegami, Tetrahedron Lett. 1997, 38, 8969-8972; 
c) 
H. Sakamoto, 
S. Nakamura, 
T. Tsuda, 
S. Hashimoto, Tetrahedron Lett. 2000, 41, 7691-7695. [21] For reviews on glycosidations of glycosyl phosphates, phosphites and other O-P derivatives, see: a) 
Z. Zhang, 
C.-H. Wong in Carbohydrates in Chemistry and Biology (Eds.: 
B. Ernst, 
G.W. Hart, 
P. Sina), VCH, Weinheim, 2000, Part I, pp. 117-134; 
b) 
H. Vankaya-lapati, 
S. Jiang, 
G. Singh, Synlett 2002, 16-25; 
c) 
E. 
R. Palmacci, 
O. 
J. Plante, 
P. 
H. Seeberger, Eur. 
J. Org. Chem. 2002, 595-606; 
d) 
S. Nakamura, 
H. Nambu, 
S. Hashimoto in Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance (Ed.: 
A. 
V. Demchenko), VCH, Weinheim, 2008, pp. 223-259. [22] a) 
U. Schmid, 
H. Waldmann, Tetrahedron Lett. 1996, 37, 3837-3840; 
b) 
U. Schmid, 
H. Waldmann, Liebigs Ann. 1997, 2573-2577. [23] Glycosyl iodides were prepared and used as donors for the preparation of \(\alpha\)-glycosides: a) 
F. 
J. Kronzer, 
C. Schuerch, Carbohydr. Res. 1974, 34, 71-78; 
b) 
M. 
J. Hadd, 
J. Gervay, Carbohydr. Res. 1999, 320, 61-69; 
c) 
S. 
N. Lam, 
J. Gervay-Hague, Carbohydr. Res. 2002, 337, 1953-1965. [24] Seeberger and co-workers reported that excellent \(\alpha\) selectivity \((\alpha /\beta = 20:1)\) was observed in the tert-butyldimethylsilyl triflate (TBSOTf)-promoted reaction of \(\beta\)-glactosyl dibutyl phosphate with a less nucleophilic \(4^{\prime}\)-O-unprotected lactoside in \(\mathrm{CH}_2\mathrm{Cl}_7 / \mathrm{Et}_2\mathrm{O}\) (1:4) at low temperature \((-78 - 20^{\circ}\mathrm{C})\) but the scope of the reaction has not been explored: 
F. Bosse, 
L. 
A. Marcaurelle, 
P. 
H. Seeberger, 
J. Org. Chem. 2002, 67, 6659-6670. [25] I. Tvaroska, 
T. Bleha, Adv. Carbohydr. Chem. Biochem. 1989, 47, 45-123. [26] T. Saitoh, 
S. Yoshida, 
J. Ichikawa, 
J. Org. Chem. 2006, 71, 6414-6419. [27] For the use of Brønsted acids as promoters in glycosidations with glycosyl phosphites, see: a) 
H. Kondo, 
S. Aoki, 
Y. Ichikawa, 
R. 
L. Halcomb, 
H. Ritzen, 
C.-H. Wong, 
J. Org. Chem. 1994, 59, 864-877; 
b) reference [19e]; 
c) reference [20c]. For the use of \(\mathrm{HClO_4}\) to activate a glycosyl diethyl phosphite, see reference [19h]. [28] The remarkable \(\alpha\)-directing effect of dioxane has already been documented by Boons and co-workers: a reference [9f]; b) reference [9i]. [29] Seeberger and co-workers demonstrated that the glycosidation reaction of a glycosyl dibutyl phosphate with a TMS ether proceeded to completion by the use of \(1\mathrm{mol}\%\) of TFSO as a promoter, since TMSOTf, generated in situ along with the desilylated alcohol, functioned as an actual promoter for the formation of the 1,2-trans- \(\beta\)-glycoside from glycosyl dibutyl phosphate: 
O. 
J. Plante, 
E. 
R. Palmacci, 
R. 
B. Andrade, 
P. 
H. Seeberger, 
J. Am. Chem. Soc. 2001, 123, 9545-9554. [30] The use of the \(0.1\mathrm{M}\) \(\mathrm{HClO_4}\) solution in the reaction of diethyl phosphite 2 with alcohol 3 exhibited diminished \(\alpha\) selectivity \((\alpha /\beta = 85:15)\), again demonstrating the superiority of phosphate 1 over phosphite 2. [31] a) 
R. 
R. Schmidt, 
M. Stumpp, Liebigs Ann. Chem. 1984, 680-691; 
b) 
R. 
R. Schmidt, 
H. Gaden, 
H. Jatzke, Tetrahedron Lett. 1990, 31, 327-330; 
c) 
R. 
R. Schmidt in Carbohydrates—Synthetic Methods and Applications in Medicinal Chemistry (Eds.: 
H. Ogura, 
A. Hasegawa, 
T. Suami), VCH, Weinheim, 1992, pp. 66-88; 
d) 
B. 
A. Garcia, 
D. 
Y. Gin, Org. Lett. 2000, 2, 2135-2138.<|md_end|>
<|box_start|>514 078 923 876<|box_end|><|ref_start|>text<|ref_end|><|md_start|>[32] A control experiment revealed that anomer equilibration of diphenyl phosphate 1 \((\alpha /\beta = 1:99)\) was effected within 30 seconds under the optimized conditions to give a 98:2 equilibrium mixture in favor of the thermodynamically more stable \(\alpha\) anomer 1a. [33] Diphenyl phosphate 1 with \(\alpha /\beta\) ratio of 5:95 was prepared by coupling per- O- benzyl- protected \(\alpha\)- glucosyl trichloroacetimidate with diphenyl phosphoric acid in \(\mathrm{CH}_2\mathrm{Cl}_2\) at \(0^\circ \mathrm{C}\). [34] Glycosidation of phosphate 1 with reactive alcohol 3 proceeded to \(90\%\) conversion during the 30 s period. [35] T. Matsumoto, M. Katsuki, K. Suzuki, Tetrahedron Lett. 1988, 29, 6935- 6938. [36] Wong and co- workers reported that the per- O- benzyl- protected thiogalactoside is 6.4- fold more active than the corresponding thiogalcoside probably owing to the stereo- and inductive effects and possible involvement of the axial \(4^{\prime}\)- O- lone pair electrons in the stabilization of the oxocarbentium ion intermediate: Z. Zhang, I. R. Ollmann, X.- S. Ye, R. Wischnat, T. Baasov, C.- H. Wong, J. Am. Chem. Soc. 1999, 121, 734- 753. [37] Wong and co- workers concluded in their report [38] that the deactivating power of substituents at C- 2 is in the order of \(- \mathrm{N}_3 > \mathrm{OCOCH}_2\mathrm{Cl} > \mathrm{NPhth} > \mathrm{OBz} > \mathrm{OBn}\). [38] a) 
T. Natori, Y. Koezuka, T. Higa, Tetrahedron Lett. 1993, 34, 5591- 5592; b) 
K. Akimoto, T. Natori, M. Morita, Tetrahedron Lett. 1993, 34, 5593- 5596; c) 
T. Natori, M. Morita, K. Akimoto, Y. Koezuka, Tetrahedron 1994, 50, 2771- 2784. [39] a) 
M. Morita, K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, H. Fukushima, J. Med. Chem. 1995, 38, 2176- 2187; b) 
M. Morita, T. Natori, K. Akimoto, T. Osawa, H. Fukushima, Y. Koezuka, Bioorg. Med. Chem. Lett. 1995, 5, 699- 704; c) 
K. Motoki, E. Kobayashi, T. Uchida, H. Fukushima, Y. Koezuka, Bioorg. Med. Chem. Lett. 1995, 5, 705- 710; d) E. Kobayashi, K. Motoki, Y. Yamaguchi, T. Uchida, H. Fukushima, Y. Koezuka, Bioorg. Med. Chem. 1996, 4, 615- 619. [40] T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, M. Taniguchi, Science 1997, 278, 1626- 1629. [41] For recent reviews, see: a) 
C. 
R. Berkers, H. Ovaa, Trends Pharmacol. Sci. 2005, 26, 252- 257; b) 
P. 
B. Savage, L. Teyton, A. Bendelac, Chem. Soc. Rev. 2006, 35, 771- 779. [42] Kirin group: a) reference [39a]; b) 
M. Morita, E. Sawa, K. Yamaji, T. Sakai, T. Natori, Y. Koezuka, H. Fukushima, K. Akimoto, Biosci. Biotechnol. Biochem. 1996, 60, 288- 292; Mori, group: c) 
H. Takiwa, S. Muto, K. Mori, Tetrahedron 1998, 54, 3141- 3150; Schmidt group: d) S. Figueroa- Perez, R. R. Schmidt, Carbohydr. Res. 2000, 328, 95- 102; Wong group: e) O. Plettenburg, V. Bodmer- Narkevitch, C.- H. Wong, J. Org. Chem. 2002, 67, 4559- 4564; Kim group: f) S. Kim, S. Song, T. Lee, S. Jung, D. Kim, Synthesis 2004, 847- 850; Lin group: g) G.- T. Fan, Y. Pan, K.- C. Lu, Y.- P. Cheng, W.- C. Lin, S. Lin, C.- H. Lin, C.- H. Wong, J.- M. Fang, C.- C. Lin, Tetrahedron 2005, 61, 1855- 1862; Gervay- Hague group: h) W. Du, J. Gervay- Hague, Org. Lett. 2005, 7, 2063- 2065; Hung group: i) S.- Y. Luo, S. S. Kulkarni, C.- H. Chou, W.- M. Liao, S.- C. Hung, J. Org. Chem. 2006, 71, 1226- 1229; Wang, group: j) C. Xia, Q. Yao, J. Schumann, E. Rossy, W. Chen, L. Zhu, W. Zhang, G. De Libero, P. G. Wang, Bioorg. Med. Chem. Lett. 2006, 16, 2195- 2199; Kiso group: k) A. Kimura, A. Imamura, H. Ando, H. Ishida, M. Kiso, Synlett 2006, 2379- 2382; Painter group: l) A. Lee, K. J. Farrand, N. Dickgreber, C. M. Hayman, S. Jürs, I. F. Hermans, G. F. Painter, Carbohydr. Res. 2006, 341, 2785- 2798; Ito group: m) T. Tsujimoto, Y. Ito, Tetrahedron Lett. 2007, 48, 5513- 5516. [43] W. Du, S. S. Kulkarni, J. Gervay- Hague, Chem. Commun. 2007, 2336- 2338. [44] a) 
R. Wild, R. R. Schmidt, Liebigs Ann. 1995, 755- 764; b) 
B. Kratzer, T. G. Mayer, R. R. Schmidt, Eur. J. Org. Chem. 1998, 291- 298. [45] G. A. Olah, C. W. McFarland, J. Org. Chem. 1971, 36, 1374- 1378. [46] C. Schuerch, ACS Symp. Ser. 1979, 87, 80- 94. [47] For evidence supporting formation of oxonium ion intermediates by participation of THF, see: a) 
B. Helferich, J. Zirner, Chem. Ber. 1963, 96, 374; b) 
G. Wulff, W. Schmidt, Carbohydr. Res. 1977, 53,<|md_end|>
--------------------------------------------------
<|box_start|>076 082 485 279<|box_end|><|ref_start|>text<|ref_end|><|md_start|>33–46; c) J. Tamura, S. Horito, J. Yoshimura, H. Hashimoto, Carbohydr. Res. 1990, 207, 153–165; d) K. Brüser, A. Vasella, Helv. Chim. Acta 1992, 75, 621–637; e) D. R. Dabideen, J. Gervay- Hague, Org. Lett. 2004, 6, 973–975. [48] R. R. Schmidt in Carbohydrates—Synthetic Methods and Applications in Medicinal Chemistry (Eds. H. Ogura, A. Hasegawa, T. Suami), VCH, Weinheim, 1992, pp. 66–88. [49] R. R. Schmidt, J. Michel, Tetrahedron Lett. 1984, 25, 821–824. [50] S. Sabesan, S. Neira, Carbohydr. Res. 1992, 223, 169–185. [51] B. A. Garcia, D. Y. Gin, J. Am. Chem. Soc. 2000, 122, 4269–4279. [52] a) M. Kreuzer, J. Thiem, Carbohydr. Res. 1986, 149, 347–361; b) M. Palme, A. Vasella, Bioorg. Med. Chem. 1994, 2, 1169–1177. [53] K. Takeo, Y. Teramoto, Y. Shimono, Carbohydr. Res. 1991, 209, 167–179. [54] a) G. Wulff, U. Schroder, J. Wichelhaus, Carbohydr. Res. 1979, 72, 280–284; b) R. R. Schmidt, J. Michel, J. Carbohydr. Chem. 1985, 4, 141–169. <|md_end|>
<|box_start|>515 082 922 252<|box_end|><|ref_start|>text<|ref_end|><|md_start|>[55] a) D. Crich, S. Sun, Tetrahedron 1998, 54, 8321–8348; b) H. Imagawa, A. Kinoshita, T. Fukuyama, H. Yamamoto, M. Nishizawa, Tetrahedron Lett. 2006, 47, 4729–4731. [56] a) H. Tsutsumi, Y. Ishido, Carbohydr. Res. 1981, 88, 61–75; b) S. Koto, N. Morishima, M. Araki, T. Tsuchiya, S. Zen, Bull. Chem. Soc. Jpn. 1981, 54, 1895–1896. [57] A. Marra, J. Esnault, A. Veyrieres, P. Sinaï, J. Am. Chem. Soc. 1992, 114, 6354–6360. [58] B. Mukhopadhyay, P. Cura, K. P. R. Kartha, C. H. Botting, R. A. Field, Org. Biomol. Chem. 2005, 3, 3468–3470. [59] a) H. Kunz, S. Birnbach, P. Wernig, Carbohydr. Res. 1990, 202, 207–223; b) S. D. Kuduk, J. B. Schwarz, X.- T. Chen, P. W. Glunz, D. Sames, G. Ragupathu, P. O. Livingston, S. J. Danishefsky, J. Am. Chem. Soc. 1998, 120, 12474–12485; c) N. Laurent, D. Lafont, P. Boullinger, Carbohydr. Res. 2006, 341, 823–825. <|md_end|>
<|box_start|>758 264 922 286<|box_end|><|ref_start|>text<|ref_end|><|md_start|>Received: April 15, 2008  Published online: July 4, 2008<|md_end|>